WO1994001056A1 - Tubular medical prosthesis - Google Patents

Tubular medical prosthesis Download PDF

Info

Publication number
WO1994001056A1
WO1994001056A1 PCT/US1993/006529 US9306529W WO9401056A1 WO 1994001056 A1 WO1994001056 A1 WO 1994001056A1 US 9306529 W US9306529 W US 9306529W WO 9401056 A1 WO9401056 A1 WO 9401056A1
Authority
WO
WIPO (PCT)
Prior art keywords
prosthesis
strand
knitted
loops
tubular
Prior art date
Application number
PCT/US1993/006529
Other languages
French (fr)
Inventor
Erik Andersen
Ernst Peter Strecker
Original Assignee
Boston Scientific Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Corporation filed Critical Boston Scientific Corporation
Priority to DE69332800T priority Critical patent/DE69332800T2/en
Priority to JP6503559A priority patent/JPH07509152A/en
Priority to CA002139564A priority patent/CA2139564C/en
Priority to EP93917107A priority patent/EP0651624B1/en
Publication of WO1994001056A1 publication Critical patent/WO1994001056A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04BKNITTING
    • D04B1/00Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
    • D04B1/14Other fabrics or articles characterised primarily by the use of particular thread materials
    • D04B1/16Other fabrics or articles characterised primarily by the use of particular thread materials synthetic threads
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04BKNITTING
    • D04B1/00Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
    • D04B1/22Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes specially adapted for knitting goods of particular configuration
    • D04B1/225Elongated tubular articles of small diameter, e.g. coverings or reinforcements for cables or hoses
    • DTEXTILES; PAPER
    • D04BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04BKNITTING
    • D04B9/00Circular knitting machines with independently-movable needles
    • D04B9/42Circular knitting machines with independently-movable needles specially adapted for producing goods of particular configuration
    • D04B9/44Circular knitting machines with independently-movable needles specially adapted for producing goods of particular configuration elongated tubular articles of small diameter, e.g. coverings for cables
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • A61F2002/9511Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument the retaining means being filaments or wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol
    • A61F2210/0019Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol operated at only one temperature whilst inside or touching the human body, e.g. constrained in a non-operative shape during surgery, another temperature only occurring before the operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0073Quadric-shaped
    • A61F2230/008Quadric-shaped paraboloidal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0048Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in mechanical expandability, e.g. in mechanical, self- or balloon expandability
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • A61L2300/604Biodegradation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2403/00Details of fabric structure established in the fabric forming process
    • D10B2403/01Surface features
    • D10B2403/011Dissimilar front and back faces
    • D10B2403/0114Dissimilar front and back faces with one or more yarns appearing predominantly on one face, e.g. plated or paralleled yarns
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00Medical; Hygiene
    • D10B2509/06Vascular grafts; stents

Definitions

  • This invention relates to tubular prostheses which are placed within the body.
  • Tubular prostheses are used in body lumens to perform various functions.
  • a tubular stent may be used to maintain the opening of an esophagus that has been restricted by a tumor or a blood vessel restricted by plaque.
  • Tubular grafts are used to substitute for or reinforce a weakened lumen, such as the aorta or other blood vessel that has been weakened by an aneurysm.
  • a graft of a knitted dacron may be used to advantage since the textured nature of the textile can induce blood clotting along the graft to contribute to the patency of the lumen formed by the graft.
  • Tubular prostheses for purposes such as the above may be positioned in the body lumen during a surgical procedure or may be delivered into the body by a catheter that supports the prosthesis in a compact form during percutaneous insertion and transport through body passageways to a desired site. Upon reaching the site, the prosthesis is expanded so that it engages the walls of the lumen. After this operation, the catheter is removed, leaving the device in the body.
  • the expansion technique may involve forcing the prosthesis to expand radially outwardly, for example, by inflation of a balloon carried by the catheter.
  • Knitted, balloon expandable stents are discussed for example in Strecker U.S. 4,922,905, the entire content of which we hereby incorporate by reference.
  • the prosthesis is formed of an elastic material that can be arranged and held in a compact form for insertion and allowed to expand when in position by its own internal elastic restoring force. Knitted self-expanding stents are described in Strecker PCT EP 91/02194 and in Anderson U.S. Serial No. 07/773,847, filed October 9, 1991, the entire contents of both applications being incorporated herein by reference.
  • the invention provides prostheses with improved properties by forming the prostheses of multiple filaments or strands of different materials, one of which is a structural filament, preferably metal.
  • the strands are knit into a tubular form.
  • multiple strands of different materials are co-knit into a stent.
  • co-knit refers to the knitting of multiple discrete strands in the knit pattern.
  • the strands are in a parallel co- knit form, by which is meant the strands of the various substances lie in parallel in all contiguous loops of the co-knit portion of the knit pattern.
  • the multiple strands of different materials are alternately knit such that adjacent rows of knit loops are of the different materials.
  • different regions of the prosthesis are formed of different sets of materials.
  • a tubular structure of a first knit material is provided as a sheath over a second tubular structure of another knit material.
  • the invention features a tubular prosthesis having a tubular wall portion of loosely interlocked knitted loops constructed to function within a body lumen.
  • the loops are formed of co-knitted strand materials where a first strand material of the loops is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of the loops is co-knitted with the metallic strand and is formed of a predetermined substance selected to provide desired characteristics to the wall of the prosthesis.
  • the invention features a vascular graft prosthesis for bridging an aneurysm in an arterial lumen of the body.
  • the graft has a tubular wall portion of loosely interlocked knitted loops constructed to function within the arterial lumen.
  • the loops are formed of co-knitted strand materials where a first strand material of the loops is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of the loops, co-knitted with the metallic strand, is formed of a predetermined non- metallic substance selected to provide desired characteristics to the wall of the prosthesis to enable it to perform its the function to effectively provide a patent covering over the structure of the graft.
  • the invention features a vascular prosthesis for use in an arterial lumen of the body.
  • the prosthesis has a tubular wall portion of loosely interlocked knitted loops constructed to function within the arterial lumen.
  • the loops are formed of parallel co-knitted strand materials where a first strand material of the loops is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of the loops, co-knitted with the metallic strand, is a textured textile strand substance selected to enhance patency characteristics of the wall of the prosthesis.
  • the invention features a tubular prosthesis.
  • the prosthesis has a tubular wall portion of loosely interlocked knitted loops constructed to function within a body lumen.
  • the loops are formed of multiple strand materials where a first strand material of the loops is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of knitted loops is formed of a predetermined substance selected to provide desired characteristics to the wall of the prosthesis.
  • the invention features a tubular prosthesis.
  • the prosthesis has a tubular wall portion of a loosely interlocked regular pattern of strands constructed to function within a body lumen.
  • the pattern is formed of multiple strand materials where a first strand material of the pattern is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of the pattern, integrated with the metallic strand as part of the pattern, is formed of a predetermined substance selected to provide desired characteristics to the wall of the prosthesis.
  • the prosthesis has an anchoring end portion of knitted loops which are knitted integrally with at least a portion of the co-knitted wall portion and formed of a strand material adapted to make contact with the wall of the body lumen to maintain the axial position of the prosthesis in the body lumen.
  • the anchoring end portion is formed of contiguous loops of the first, metal strand material joined integrally with the the wall portion that includes the co-knit second strand.
  • the anchoring end portion of the prosthesis is sel -expanding and is formed of elastic metal strand capable of being reduced in radial size without plastic deformation and retaining self-restoring capability such that the end portion can be reduced to a relatively small size for introduction lengthwise into the lumen, and when freed can radially self-expand to tubular form to engage the wall of the lumen.
  • the anchoring end portion is formed of the plastically deformable metal and is knit integrally with the wall portion.
  • the anchoring end portion is formed of metal strand flared to a diameter greater than the wall portion.
  • the prosthesis has an anchoring portion at each of its axial ends.
  • the wall portion is expandable to desired size by means of an internal expanding force or is self-expanding.
  • the first strand material of the wall portion is a plastically deformable metal and the wall portion is expandable to a desired size by application of an internal expanding force.
  • the first strand is selected from tantalum and nitinol.
  • the second strand is selected from dacron, wool, nylon, polyethylene and teflon.
  • the material of the second strand is textured to induce blood clotting.
  • the prosthesis is sized for use as an aortic graft having, for example a porosity of about 4000 ml/min or more at implantation.
  • the second strand is formed of a body fluid-dissolvable suture material.
  • the second strand is an absorbing member that includes a drug.
  • the second strand material is a metal, such as a dense metal that enhances the radiopacity of the prosthesis.
  • the co- knit strands are in a parallel co-knit pattern.
  • the first strand material and second strand material are continuously, single knitted to form regions of the tubular knit structure formed of the first material and regions of the knit structure formed of the second material.
  • the first and second strand materials are alternately knitted to form successive alternating loop rows of the first and second material.
  • the first and second strand materials are formed as separate knitted loop tubular structures and the second strand knitted loop structure extends coaxially with the first strand knitted loop structure and extends over an end of the first strand knitted loop structure to form a cuff to secure the first knitted structure to the second knitted structure.
  • the tubular prosthesis pattern is formed by co-weaving or co-crocheting the strands, such as into a pattern formed of multiple parallel strands.
  • the invention also includes methods for manufacture and use of the prostheses described. Still other aspects of the invention will be understood from the following description and from the claims. Description of the Preferred Embodiment
  • Fig. 1 is a side view, in magnified scale, of an aortic graft prosthesis according to the invention using two different strand materials co-knit into a tubular structure in parallel co-knit fashion, while Fig. la is a greatly expanded view of adjacent loops in the wall portion of the graft of Fig. 1;
  • Fig. 2 is a side view of another prosthesis according to the invention.
  • Fig. 3 is a side view of another prosthesis according to the invention, while Fig. 3a is an enlarged view of a portion of the prosthesis of Fig. 3;
  • Fig. 4 is a side view of another prosthesis according to the invention.
  • Fig. 5 is a side view of another prosthesis according to the invention
  • Fig. 5a is an end view taken at line aa of Fig. 5
  • Fig. 5b is a cross-section view taken at line bb of Fig. 5
  • Fig. 5c is an enlarged side view of the prosthesis of Fig. 5.
  • Fig. 6 is a diagrammatic view of a circular knitting machine configured for alternate knitting while Figs. 6a-6d illustrate the operation of a needle used in a circular knitting machine and Fig. 6e illustrates a circular knitting machine configured for parallel co- knitting.
  • Figs. 7-7d illustrate schematically, on a reduced scale, placement of an embodiment of an aortic graft prosthesis in the body. Description
  • an embodiment of a prosthesis according to the invention is a graft 10 which may be positioned in the abdominal aorta 38 within an aneurysm 40.
  • the graft 10, of overall length L x e.g., about 8 cm, includes a wall portion 12, of length L 2 , e.g., about 5 cm, that spans the aneurysm 40 and anchoring end portions 14, 14', each of length L 3 , e.g., about 1.5 cm, that engage healthy portions of the aorta to anchor the prosthesis in the lumen.
  • the graft 10 is formed of loosely interlocked knitted loops of material.
  • the diameter d of the graft 10 and the respective lengths are variable, as discussed below, to accommodate various aorta diameters and aneursym conditions.
  • the diameters may be in the range of 10-20 mm and prosthesis lengths L x in the range of about 4-8 cm.
  • the loops are formed by parallel co-knitting of a first strand material 16, a metal, and a second strand material 18, preferably of texturized filament or fiber.
  • the first strand material substantif ly defines the tubular structure of the graft and is a selected metal strand of wire such as tantalum.
  • the second strand material 18 is preferably non-metallic, e.g. a polymer or natural textile fiber or the like, such as a textile yarn, selected to provide a desired characteristic of the prosthesis to enable it to perform a desired function.
  • the second material is selected for its capability of inducing the clotting of blood.
  • the second strand material 18 is preferably a texturized material such as dacron yarn formed of crimped or texturized multiple monofilaments, typically in excess of about 20, with multiple, randomly extending segments 22 that extend into the open area 25 between adjacent knitted loops.
  • the anchoring portions 14, 14' are formed of wire knitted strand 24, that does not include a co-knit strand.
  • Strand 24 is integral with the wall portion 12 and may be a knitted extension of the metal strand material 16.
  • the anchoring end portions may be a co-knit structure which may be the same or different from the co-knit structure of the central wall portion.
  • a particular aspect of this embodiment is parallel co-knitting to form rather loosely interlocked loops with selected, loop length, L 4 , e.g. about 1.8 mm that provides substantial open area 25.
  • This design facilitates wrapping the prosthesis into small size for delivery intralumenally. Wrapping produces a sliding action of adjacent loops within the open area that avoids stress concentrations in the wires, yet the size of the open area and texturized nature and number of strands formed of the second material provides strand components that extend within the open areas of the loops. By suitable selection, these components can be sufficient to produce clotting in a sufficiently short time that excessive bleeding through the graft will not occur when the graft is placed inside the lumen.
  • the graft need not be pre-clotted before placement. Over time in the body, the graft accepts cells, endothelializes and becomes a patent portion of the artery.
  • the porosity of the graft may be, e.g., about 4000 ml/min or more at implantation. This degree of porosity facilitates migration of cells (e.g. fibroblasts and endothelial cells) into and through the knit structure such that cellular structure can be formed. (Graft porosity as measured by water filtration testing is discussed, for example, in Wesolowski, S.A. Dennis, C. , Fundamentals of Vascular Grafting. New York, McGraw-Hill, 1963.)
  • the loosely interlocked loops formed by the co-knitting process of metal wire and the other selected substance are free to slide with respect to each other while in use in the body.
  • This ability for the loops to slide enhances the ability of the device to maintain its axial working length and resist migration when the prosthesis is locally radially compressed. Under such compression the loop structure may locally lengthen or shorten to accommodate similar changes in the vessel in which it is installed, as may occur for instance if the aorta is stretched.
  • the loosely co- knitted structure also allows the graft to negotiate tortuous vasculature during delivery on a catheter because of its flexibility longitudinally.
  • the co-knitting has other advantages as well.
  • a graft as in Fig. 1 and la employs, in parallel with the metal stiand, four parallel strands of dacron (44DTEX) , each strand consisting of 27 filaments, full drawn R02 medical grade (available from E.I. DuPont de Nemours and Co., Wilmington, DE) .
  • the strands are texturized by false twisting and set by radiation heating.
  • Parallel co-knitting with a tantalum wire strand (0.10 mm) is carried out to produce a 10 mm diameter (d 2 ) graft with a circumferential loop count of 12 loops and a wall portion of 4 cm length (L 2 ) consisting of 29 co-knit rows and anchoring end portions, of 10 single knit rows of tantalum.
  • the loop length of the knitted loops in the axial direction is about 1.8 mm.
  • the principle of combining different strands to form a prosthesis provides a ready ability to adapt the properties of the stent to suit various applications, the respective strands being selected to provide properties which enhance performance.
  • At least one of the strands will be selected for its structural properties to enable the stent to maintain an open passage.
  • such strands are of selected metal.
  • the metal strand material may be of a metal selected to enhance radiographic visualization of the prosthesis during the delivery through a body lumen, the positioning at a desired site and the assessing of the efficacy of treatment. Particular advantages are achieved when the metal strand is formed of a highly radiopaque metal such as tantalum.
  • the metal strand material also may be selected for features relating to its expandability, to enable a single size-prosthesis to be manufactured for use in lumens of somewhat varying size as may be encountered from patient to patient.
  • the metal strand material may be a metal capable of yielding when the stent is expanded in the lumen by an internal radial force, such as by balloon expansion. Such a prosthesis is therefore size- selectable for the desired application.
  • the metal strand material is selected to form an elastically self-expanding prosthesis which may be reduced to a small diameter for introduction into the body and allowed to expand at a desired site by release of a restraint.
  • an elastic metal strand such as nitinol wire, which also can enhance maintenance of the elasticity of the vessel in which it is placed and can be used to widen an occluded vessel.
  • the prosthesis may be used as a stent in the biliary duct or the esophagus to widen these ducts in the cases where they have been occluded by tumors.
  • the co-knit portions may still require balloon expansion because of the restraining effect of the second strand, or to ensure good seating.
  • the metal strand may also comprise a two component cored material as discussed in USSN 07/861,253, filed March 31, 1992, the entire contents of which are hereby incorporated by reference.
  • the second strand material may be a wool, nylon, polyester, polyethylene or teflon, selected e.g.
  • Various embodiments may also include a strand adapted for drug delivery.
  • the second strand material may also be a dissolvable suture material or an absorbent such as hollow absorbent material carrying drug that inhibits body rejection of the prosthesis or inhibits hyperplasia.
  • the drug may be slowly releasable as the strand dissolves, finally leaving only the thin metal first strand to provide desired reinforcing structure through the loops of which healthy endothelial tissue can gradually grow without the chaffing or grinding effects that might occur at points of intersection of the strands that have dissolved.
  • both the first and second strands are metals that provide different desirable properties.
  • one strand may be an elastic material such as nitinol and the second strand a dense radiopaque strand such as tantalum that enhances the fluoroscopic visibility of the device.
  • one or both of the metal strands include a polymer coating to avoid electrolytic corrosion induced by contact of dissimilar metals in an aqueous body fluid environment.
  • the coating may be selected to be dissolvable.
  • a drug may be incorporated in the coating so that, by the dissolving action, the drug is released over time.
  • the rate of dissolution of a coating may be selected so that removal of the coating occurs at a desired time, to enable electrolytic corrosion to dissolve one of the strands, thereby to reduce the amount of metal remaining in the body.
  • the coating may also be seeded with fibrin on the surface to control a fibrin layer with the aim of forming neuro intima.
  • a strand material employing a semipermeable membrane for drug delivery can also be used. One such material is described in EP 0441516, published August 8, 1991, the entire contents of which is hereby incorporated by reference.
  • the anchoring portions 14, 14' can be, for example, axial knitted extensions of the metal strand material 16 which may be produced by ceasing co-knitting of the second strand material at a desired point in production.
  • a second metal strand which can be of the same or different properties from the first metal can be added in this region to strengthen the anchoring portions or for other purposes.
  • aortic graft in certain cases, as discussed above with respect to Figs. 1 and la, it is particularly advantageous not to have clot-producing strands in the anchoring region so that substantial clotting will not be induced at the end portions where it is not necessary and the mechanical properties of the metal strand can perform their function unimpeded to provide secure anchorage.
  • the strands at the end portions may be selected to be elastic, self-expanding, or plastically deformable.
  • the metal strand at the anchoring ends may be a different strand material than either the first strand material or second strand material in the main body or wall portion of the stent, to produce a desired effect, such as self-expandability in the anchoring ends and balloon expandability in the wall portion.
  • the anchoring end material can be co-knit to overlap with a portion of the wall portion.
  • a prosthesis 26 having a wall portion 12 and anchoring ends 28, 28'.
  • ends 28, 28' are flared outwardly to a diameter, d 2 , such that they impress upon the inner wall of a body lumen 2 for anchoring the prosthesis 26 in place.
  • the strands 25 at the anchoring ends may be selected to make the ends self-expanding or expanded by plastic deformation by an internal expansion device.
  • a stent 50 may be formed by continuous knitting a first strand material 52 and a second strand material 54 in an alternating, sequential co-knit fashion to form adjacent spiral patterns of loops along the length of the stent, resulting in successive alternating rows of different material in a single knit structure.
  • strand 52 is a metal strand, most preferably tantalum
  • second strand 54 is a dissolvable, resorbable thread of material such as is used in dissolvable sutures.
  • the thread strand 54 is dissolved leaving only circumferential rings of successive loops of metal which avoids strand intersections that could exert shearing forces or other damaging effects on surrounding and growing tissue.
  • drugs e.g., an antiproliferative
  • the first strand is a metal selected for its elastic properties and the second strand is a radiopaque metal, with one or both of the metals including a coating to inhibit, at least temporarily, the electrolytic degradation of the strands, as mentioned above.
  • stent 60 is formed by continuous knitting of a first strand 62, preferably a metal such as tantalum and a second strand 64 such as dacron in alternating regions, to perform specific functions.
  • Metal strand 62 in the end regions provide anchoring portions while textile strand 64 provides a patent graft region.
  • a graft 70 is provided that is formed of a first, separately knitted tubular structure 72 formed of a first strand 73, e.g. tantalum, and a second separately tubular knitted structure 74, assembled coaxially within the first structure 72 and formed of a second strand 75, e.g. dacron.
  • the second tubular knit structure 74 is rolled over the outside of the first knit structure to form a cuff, to secure the assembly together.
  • the first and second tubular knit structures may also be secured by sewing them together.
  • the second tubular knitted structure of dacron could be a continuously co-knitted extension of the first metal tubular structure and the dacron knitted structure is pulled through the center of the metal structure.
  • the fabric knitted structure is on the outside of the metal knitted structure or is sandwiched between two metal structures or the metal knitted structure is between two fabric knitted structures.
  • two tubular members can be effectively formed as a double knit structure.
  • the prostheses are formed of knitted strands
  • other methods of forming a tubular structure from strands such as co- weaving, co-crocheting and the like can also be used.
  • a velour which is a variant of knitted material in which loops of yarn extend outward from the surface of the fabric formed by the knit structure.
  • Tubular prostheses of the invention may be manufactured on a circular knitting apparatus.
  • knitting apparatus are diagrammatically shown.
  • the apparatus includes a knitting head 92 for guiding a series of needles 94, 94' which are axially extended and retracted by a rotating (arrow 95) contoured platen 96.
  • Spools 98, 98 ' feed strand material to the needles during the knitting operation.
  • the knit structure 101 is produced around a plastic mandrel 100 which is drawn downward in the direction of arrow 102.
  • the needles such as needle 94, include a needle head 106 and a pivoted needle tongue 108.
  • the head 106 grasps a feed from the strand spool 98, the tongue 108 being initially in the downward position (Fig. 6a) .
  • the tongue 108 is deflected upward as it engages the portion of the knitting head 94, thus enclosing the strand within the head (Fig. 6b) .
  • the downstroke continues for a selected length within the knitting head (Fig. 6c) .
  • the strand deflects the tongue 108 downward, thus releasing the strand from the needle head 106 (Fig. 6d) .
  • the cycle is repeated as the platen 96 rotates.
  • the contour of the platen is selected to drive the needles for forming a desired knit pattern.
  • needles 94, 94' disposed about the needle head 92 at 180° are synchronized to simultaneously pass through the stroke cycle by platen 96 which is contoured symmetrically with opposed raised sections 99, 99' and intervening valleys.
  • the knit pattern will be a continuous alternating tubular knit structure 101 such as that described with respect to Fig. 3, above.
  • multiple strands are passed through each needle head to cause simultaneous parallel co-knitting.
  • the circular knitting machine is shown configured for parallel co-knitting by providing strands from spools
  • a platen 118 is provided which has a single raised section 120 to sequentially drive each needle about the periphery of the knitting head through the stroke cycle.
  • the parallel co-knit structure 103 is formed on mandrel 100. Co-knitting may be ceased by providing only a single strand to the needle heads, for example when knitting a graft such as in Fig. 1, with a co-knit wall portion and integral single knit anchoring end portions.
  • the number of needles circumferentially disposed around the knitting head determines the number of circumferential knit loops.
  • the size of the needle affects the narrowness of the loops; a smaller needle forms a narrower loop since the strand bends more acutely around the narrower needle head.
  • the diameter of the knitting head affects the diameter of the knitted stent. Delivery
  • the prostheses of the invention can be positioned by various means.
  • the graft may be positioned using a catheter with a balloon having a length substantially the length of the graft and an inflated diameter sufficient to expand the graft to the desired maximum size and to smaller sizes by partial inflation.
  • the graft can be restrained to small size on a catheter with a constraint such as a sleeve which is removed to release the stent at the placement site.
  • These self- expanding grafts may be wrapped around a distal portion of the catheter in a 'jelly roll' fashion.
  • a graft having self-expanding anchoring ends and a balloon expandable wall portion is illustrated.
  • the graft 80 is positioned at the distal end of a catheter 30 which includes an inflatable balloon 32 upon which the graft is placed and an axially slidable sleeve member 34 which is placed over the graft 80 to constrain the self-expanding anchoring ends 82, 82' and a balloon wall portion formed of a co-knit tubular structure including a clot-inducing strand and a metal strand.
  • the catheter 30, which for introduction through a vessel such as the iliac artery 36 has a diameter of about 20 French, is advanced to the aorta 38 that has been weakened by an aneurysm 40.
  • the catheter 30 positions the graft such that graft 80 spans the region effected by aneurysm 40 and axially therebeyond to portions 42, 44 of the aorta that remain healthy but such that the graft will not interfere with the renal arteries 41.
  • a smaller catheter about 12 F
  • the stent is constructed with a 5 to 1 ratio of expanded to compressed size.
  • Placement of the graft should be accurate to within about +/- 0.5 cm to properly position the anchoring ends 80, 80' which are typically about:A.5 cm in length on the healthy portions of ⁇ the aorta.
  • the graft 80 is placed in the lumen by withdrawing the sleeve 34 axially (arrow 46) which releases the restraint on end portion 82' causing it to expand to engage the inner wall of the healthy portion 44 of the aorta.
  • the anchoring end 82 similarly expands to engage the healthy portion 42 of the aorta, thus fixing the prosthesis in the lumen and positioning the wall portion 84, which remains unexpanded, at the location of the aneurysm 40.
  • the balloon 32 is inflated to produce a radial force (arrow 48) which expands the wall portion 84 to a desired diameter that approximates the diameter of the healthy portions of the aorta such that the wall portion of the graft does not engage the weakened tissue of the aneurysm.
  • the balloon 32 can be deflated and the catheter removed from the lumen, leaving the prosthesis 80 positioned across the aneurysm and securely anchored.
  • clotting is induced by a non-metallic textured strand of the graft to fill the interstices between adjacent knitted loops within a reasonable time to form a patent covering over the wall portion of the graft.

Abstract

A tubular prosthesis (10) including a tubular wall portion (12) of loosely interlocked pattern, e.g. of knitted loops, constructed to function within a body lumen. The loops are preferably formed of co-knitted strand materials. A first strand material (16) is a metal strand that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen. A second strand material (18) is a predetermined substance selected to provide desired characteristics to the wall of the prosthesis.

Description

TUBULAR MEDICAL PROSTHESIS
Field of the Invention This invention relates to tubular prostheses which are placed within the body.
Background of the Invention Tubular prostheses are used in body lumens to perform various functions. For example, a tubular stent may be used to maintain the opening of an esophagus that has been restricted by a tumor or a blood vessel restricted by plaque. Tubular grafts are used to substitute for or reinforce a weakened lumen, such as the aorta or other blood vessel that has been weakened by an aneurysm. In this latter technique, a graft of a knitted dacron may be used to advantage since the textured nature of the textile can induce blood clotting along the graft to contribute to the patency of the lumen formed by the graft.
Tubular prostheses for purposes such as the above may be positioned in the body lumen during a surgical procedure or may be delivered into the body by a catheter that supports the prosthesis in a compact form during percutaneous insertion and transport through body passageways to a desired site. Upon reaching the site, the prosthesis is expanded so that it engages the walls of the lumen. After this operation, the catheter is removed, leaving the device in the body.
The expansion technique may involve forcing the prosthesis to expand radially outwardly, for example, by inflation of a balloon carried by the catheter. Knitted, balloon expandable stents are discussed for example in Strecker U.S. 4,922,905, the entire content of which we hereby incorporate by reference. In another technique, the prosthesis is formed of an elastic material that can be arranged and held in a compact form for insertion and allowed to expand when in position by its own internal elastic restoring force. Knitted self-expanding stents are described in Strecker PCT EP 91/02194 and in Anderson U.S. Serial No. 07/773,847, filed October 9, 1991, the entire contents of both applications being incorporated herein by reference.
Summary of the Invention The invention provides prostheses with improved properties by forming the prostheses of multiple filaments or strands of different materials, one of which is a structural filament, preferably metal. In preferred embodiments, the strands are knit into a tubular form. In some embodiments, multiple strands of different materials are co-knit into a stent. The term "co-knit" as used herein refers to the knitting of multiple discrete strands in the knit pattern. In certain preferred embodiments, the strands are in a parallel co- knit form, by which is meant the strands of the various substances lie in parallel in all contiguous loops of the co-knit portion of the knit pattern. In other embodiments, the multiple strands of different materials are alternately knit such that adjacent rows of knit loops are of the different materials. In some embodiments, different regions of the prosthesis are formed of different sets of materials. In still further embodiments, a tubular structure of a first knit material is provided as a sheath over a second tubular structure of another knit material.
In one particular aspect, the invention features a tubular prosthesis having a tubular wall portion of loosely interlocked knitted loops constructed to function within a body lumen. The loops are formed of co-knitted strand materials where a first strand material of the loops is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of the loops is co-knitted with the metallic strand and is formed of a predetermined substance selected to provide desired characteristics to the wall of the prosthesis.
In another particular aspect, the invention features a vascular graft prosthesis for bridging an aneurysm in an arterial lumen of the body. The graft has a tubular wall portion of loosely interlocked knitted loops constructed to function within the arterial lumen. The loops are formed of co-knitted strand materials where a first strand material of the loops is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of the loops, co-knitted with the metallic strand, is formed of a predetermined non- metallic substance selected to provide desired characteristics to the wall of the prosthesis to enable it to perform its the function to effectively provide a patent covering over the structure of the graft.
In another particular aspect, the invention features a vascular prosthesis for use in an arterial lumen of the body. The prosthesis has a tubular wall portion of loosely interlocked knitted loops constructed to function within the arterial lumen. The loops are formed of parallel co-knitted strand materials where a first strand material of the loops is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of the loops, co-knitted with the metallic strand, is a textured textile strand substance selected to enhance patency characteristics of the wall of the prosthesis.
In another particular aspect, the invention features a tubular prosthesis. The prosthesis has a tubular wall portion of loosely interlocked knitted loops constructed to function within a body lumen. The loops are formed of multiple strand materials where a first strand material of the loops is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of knitted loops is formed of a predetermined substance selected to provide desired characteristics to the wall of the prosthesis. In yet another particular aspect, the invention features a tubular prosthesis. The prosthesis has a tubular wall portion of a loosely interlocked regular pattern of strands constructed to function within a body lumen. The pattern is formed of multiple strand materials where a first strand material of the pattern is a metal wire that structurally defines the tubular shape of the prosthesis and maintains the shape when positioned in the lumen and a second strand material of the pattern, integrated with the metallic strand as part of the pattern, is formed of a predetermined substance selected to provide desired characteristics to the wall of the prosthesis.
The features of the above aspects can be combined. In addition, various embodiments may include one or more of the following features. The prosthesis has an anchoring end portion of knitted loops which are knitted integrally with at least a portion of the co-knitted wall portion and formed of a strand material adapted to make contact with the wall of the body lumen to maintain the axial position of the prosthesis in the body lumen. The anchoring end portion is formed of contiguous loops of the first, metal strand material joined integrally with the the wall portion that includes the co-knit second strand. The anchoring end portion of the prosthesis is sel -expanding and is formed of elastic metal strand capable of being reduced in radial size without plastic deformation and retaining self-restoring capability such that the end portion can be reduced to a relatively small size for introduction lengthwise into the lumen, and when freed can radially self-expand to tubular form to engage the wall of the lumen. The anchoring end portion is formed of the plastically deformable metal and is knit integrally with the wall portion. The anchoring end portion is formed of metal strand flared to a diameter greater than the wall portion. The prosthesis has an anchoring portion at each of its axial ends. The wall portion is expandable to desired size by means of an internal expanding force or is self-expanding. The first strand material of the wall portion is a plastically deformable metal and the wall portion is expandable to a desired size by application of an internal expanding force. The first strand is selected from tantalum and nitinol. The second strand is selected from dacron, wool, nylon, polyethylene and teflon. The material of the second strand is textured to induce blood clotting. The prosthesis is sized for use as an aortic graft having, for example a porosity of about 4000 ml/min or more at implantation. The second strand is formed of a body fluid-dissolvable suture material. The second strand is an absorbing member that includes a drug. The second strand material is a metal, such as a dense metal that enhances the radiopacity of the prosthesis. The co- knit strands are in a parallel co-knit pattern. The first strand material and second strand material are continuously, single knitted to form regions of the tubular knit structure formed of the first material and regions of the knit structure formed of the second material. The first and second strand materials are alternately knitted to form successive alternating loop rows of the first and second material. The first and second strand materials are formed as separate knitted loop tubular structures and the second strand knitted loop structure extends coaxially with the first strand knitted loop structure and extends over an end of the first strand knitted loop structure to form a cuff to secure the first knitted structure to the second knitted structure. Rather than knitting, the tubular prosthesis pattern is formed by co-weaving or co-crocheting the strands, such as into a pattern formed of multiple parallel strands.
The invention also includes methods for manufacture and use of the prostheses described. Still other aspects of the invention will be understood from the following description and from the claims. Description of the Preferred Embodiment
We first briefly describe the drawings. Drawings
Fig. 1 is a side view, in magnified scale, of an aortic graft prosthesis according to the invention using two different strand materials co-knit into a tubular structure in parallel co-knit fashion, while Fig. la is a greatly expanded view of adjacent loops in the wall portion of the graft of Fig. 1;
Fig. 2 is a side view of another prosthesis according to the invention;
Fig. 3 is a side view of another prosthesis according to the invention, while Fig. 3a is an enlarged view of a portion of the prosthesis of Fig. 3;
Fig. 4 is a side view of another prosthesis according to the invention;
Fig. 5 is a side view of another prosthesis according to the invention; Fig. 5a is an end view taken at line aa of Fig. 5; Fig. 5b is a cross-section view taken at line bb of Fig. 5; and Fig. 5c is an enlarged side view of the prosthesis of Fig. 5. Fig. 6 is a diagrammatic view of a circular knitting machine configured for alternate knitting while Figs. 6a-6d illustrate the operation of a needle used in a circular knitting machine and Fig. 6e illustrates a circular knitting machine configured for parallel co- knitting.
Figs. 7-7d illustrate schematically, on a reduced scale, placement of an embodiment of an aortic graft prosthesis in the body. Description
Referring to Figs. 1 and la, an embodiment of a prosthesis according to the invention is a graft 10 which may be positioned in the abdominal aorta 38 within an aneurysm 40. The graft 10, of overall length Lx, e.g., about 8 cm, includes a wall portion 12, of length L2, e.g., about 5 cm, that spans the aneurysm 40 and anchoring end portions 14, 14', each of length L3, e.g., about 1.5 cm, that engage healthy portions of the aorta to anchor the prosthesis in the lumen. As illustrated, the graft 10 is formed of loosely interlocked knitted loops of material. The diameter d of the graft 10 and the respective lengths are variable, as discussed below, to accommodate various aorta diameters and aneursym conditions. For example, the diameters may be in the range of 10-20 mm and prosthesis lengths Lx in the range of about 4-8 cm.
Referring particularly to Fig. la, in the wall portion 12, the loops are formed by parallel co-knitting of a first strand material 16, a metal, and a second strand material 18, preferably of texturized filament or fiber. The first strand material substantif ly defines the tubular structure of the graft and is a selected metal strand of wire such as tantalum. The second strand material 18 is preferably non-metallic, e.g. a polymer or natural textile fiber or the like, such as a textile yarn, selected to provide a desired characteristic of the prosthesis to enable it to perform a desired function. In the case of an aortic graft, the second material is selected for its capability of inducing the clotting of blood. In these embodiments, the second strand material 18 is preferably a texturized material such as dacron yarn formed of crimped or texturized multiple monofilaments, typically in excess of about 20, with multiple, randomly extending segments 22 that extend into the open area 25 between adjacent knitted loops.
The anchoring portions 14, 14' are formed of wire knitted strand 24, that does not include a co-knit strand. Strand 24 is integral with the wall portion 12 and may be a knitted extension of the metal strand material 16. (Alternately, the anchoring end portions may be a co-knit structure which may be the same or different from the co-knit structure of the central wall portion.)
A particular aspect of this embodiment is parallel co-knitting to form rather loosely interlocked loops with selected, loop length, L4, e.g. about 1.8 mm that provides substantial open area 25. This design facilitates wrapping the prosthesis into small size for delivery intralumenally. Wrapping produces a sliding action of adjacent loops within the open area that avoids stress concentrations in the wires, yet the size of the open area and texturized nature and number of strands formed of the second material provides strand components that extend within the open areas of the loops. By suitable selection, these components can be sufficient to produce clotting in a sufficiently short time that excessive bleeding through the graft will not occur when the graft is placed inside the lumen. A particular benefit of this design is that, generally, the graft need not be pre-clotted before placement. Over time in the body, the graft accepts cells, endothelializes and becomes a patent portion of the artery. The porosity of the graft may be, e.g., about 4000 ml/min or more at implantation. This degree of porosity facilitates migration of cells (e.g. fibroblasts and endothelial cells) into and through the knit structure such that cellular structure can be formed. (Graft porosity as measured by water filtration testing is discussed, for example, in Wesolowski, S.A. Dennis, C. , Fundamentals of Vascular Grafting. New York, McGraw-Hill, 1963.)
Further, the loosely interlocked loops formed by the co-knitting process of metal wire and the other selected substance are free to slide with respect to each other while in use in the body. This ability for the loops to slide enhances the ability of the device to maintain its axial working length and resist migration when the prosthesis is locally radially compressed. Under such compression the loop structure may locally lengthen or shorten to accommodate similar changes in the vessel in which it is installed, as may occur for instance if the aorta is stretched. The loosely co- knitted structure also allows the graft to negotiate tortuous vasculature during delivery on a catheter because of its flexibility longitudinally. The co-knitting has other advantages as well. For instance, it provides a mechanism for attachment of multiple strand materials without need for additional means such as tie strands and the like, although these optionally may be employed. One embodiment of a graft as in Fig. 1 and la employs, in parallel with the metal stiand, four parallel strands of dacron (44DTEX) , each strand consisting of 27 filaments, full drawn R02 medical grade (available from E.I. DuPont de Nemours and Co., Wilmington, DE) . Before co-knitting, the strands are texturized by false twisting and set by radiation heating. Parallel co-knitting with a tantalum wire strand (0.10 mm) is carried out to produce a 10 mm diameter (d2) graft with a circumferential loop count of 12 loops and a wall portion of 4 cm length (L2) consisting of 29 co-knit rows and anchoring end portions, of 10 single knit rows of tantalum. The loop length of the knitted loops in the axial direction is about 1.8 mm. Other Embodiments Generally, the principle of combining different strands to form a prosthesis provides a ready ability to adapt the properties of the stent to suit various applications, the respective strands being selected to provide properties which enhance performance. In general, at least one of the strands will be selected for its structural properties to enable the stent to maintain an open passage. In many preferred embodiments such strands are of selected metal. The metal strand material may be of a metal selected to enhance radiographic visualization of the prosthesis during the delivery through a body lumen, the positioning at a desired site and the assessing of the efficacy of treatment. Particular advantages are achieved when the metal strand is formed of a highly radiopaque metal such as tantalum. The metal strand material also may be selected for features relating to its expandability, to enable a single size-prosthesis to be manufactured for use in lumens of somewhat varying size as may be encountered from patient to patient. The metal strand material may be a metal capable of yielding when the stent is expanded in the lumen by an internal radial force, such as by balloon expansion. Such a prosthesis is therefore size- selectable for the desired application. In other cases, the metal strand material is selected to form an elastically self-expanding prosthesis which may be reduced to a small diameter for introduction into the body and allowed to expand at a desired site by release of a restraint. Embodiments in this case would use an elastic metal strand such as nitinol wire, which also can enhance maintenance of the elasticity of the vessel in which it is placed and can be used to widen an occluded vessel. For example, the prosthesis may be used as a stent in the biliary duct or the esophagus to widen these ducts in the cases where they have been occluded by tumors. In the case of stents formed by co-knitting another strand with a self-expanding elastic metal, the co-knit portions may still require balloon expansion because of the restraining effect of the second strand, or to ensure good seating. The metal strand may also comprise a two component cored material as discussed in USSN 07/861,253, filed March 31, 1992, the entire contents of which are hereby incorporated by reference. The second strand material may be a wool, nylon, polyester, polyethylene or teflon, selected e.g. for the degree of texture desired. Various embodiments may also include a strand adapted for drug delivery. The second strand material may also be a dissolvable suture material or an absorbent such as hollow absorbent material carrying drug that inhibits body rejection of the prosthesis or inhibits hyperplasia. The drug may be slowly releasable as the strand dissolves, finally leaving only the thin metal first strand to provide desired reinforcing structure through the loops of which healthy endothelial tissue can gradually grow without the chaffing or grinding effects that might occur at points of intersection of the strands that have dissolved. In other embodiments, both the first and second strands are metals that provide different desirable properties. For example, one strand may be an elastic material such as nitinol and the second strand a dense radiopaque strand such as tantalum that enhances the fluoroscopic visibility of the device. Preferably, in these latter embodiments, one or both of the metal strands include a polymer coating to avoid electrolytic corrosion induced by contact of dissimilar metals in an aqueous body fluid environment. The coating may be selected to be dissolvable. A drug may be incorporated in the coating so that, by the dissolving action, the drug is released over time. The rate of dissolution of a coating may be selected so that removal of the coating occurs at a desired time, to enable electrolytic corrosion to dissolve one of the strands, thereby to reduce the amount of metal remaining in the body. The coating may also be seeded with fibrin on the surface to control a fibrin layer with the aim of forming neuro intima. A strand material employing a semipermeable membrane for drug delivery can also be used. One such material is described in EP 0441516, published August 8, 1991, the entire contents of which is hereby incorporated by reference.
Different portions of a prosthesis can be tailored with specific, different properties, to achieve different functions, by using various strands of different materials at different locations, which are easily implemented during the knitting process. As illustrated above in Figs. 1 and la, the anchoring portions 14, 14' can be, for example, axial knitted extensions of the metal strand material 16 which may be produced by ceasing co-knitting of the second strand material at a desired point in production. In some cases a second metal strand which can be of the same or different properties from the first metal can be added in this region to strengthen the anchoring portions or for other purposes.
In certain cases of an aortic graft, as discussed above with respect to Figs. 1 and la, it is particularly advantageous not to have clot-producing strands in the anchoring region so that substantial clotting will not be induced at the end portions where it is not necessary and the mechanical properties of the metal strand can perform their function unimpeded to provide secure anchorage. The strands at the end portions may be selected to be elastic, self-expanding, or plastically deformable.
Alternatively, the metal strand at the anchoring ends may be a different strand material than either the first strand material or second strand material in the main body or wall portion of the stent, to produce a desired effect, such as self-expandability in the anchoring ends and balloon expandability in the wall portion. The anchoring end material can be co-knit to overlap with a portion of the wall portion.
Referring to Fig. 2, a prosthesis 26 is illustrated having a wall portion 12 and anchoring ends 28, 28'. In this embodiment ends 28, 28' are flared outwardly to a diameter, d2, such that they impress upon the inner wall of a body lumen 2 for anchoring the prosthesis 26 in place. As with the embodiments above, the strands 25 at the anchoring ends may be selected to make the ends self-expanding or expanded by plastic deformation by an internal expansion device. Referring to Figs. 3 and 3a, in another embodiment, rather than parallel co-knitting, a stent 50 may be formed by continuous knitting a first strand material 52 and a second strand material 54 in an alternating, sequential co-knit fashion to form adjacent spiral patterns of loops along the length of the stent, resulting in successive alternating rows of different material in a single knit structure. In preferred embodiments, strand 52 is a metal strand, most preferably tantalum, and second strand 54 is a dissolvable, resorbable thread of material such as is used in dissolvable sutures. In a predetermined time, in the body, the thread strand 54 is dissolved leaving only circumferential rings of successive loops of metal which avoids strand intersections that could exert shearing forces or other damaging effects on surrounding and growing tissue. In preferred embodiments, drugs e.g., an antiproliferative, can be embedded in the dissolvable strand to gradually deliver the drug to surrounding tissue as the strand dissolves. In an alternative preferred embodiment, the first strand is a metal selected for its elastic properties and the second strand is a radiopaque metal, with one or both of the metals including a coating to inhibit, at least temporarily, the electrolytic degradation of the strands, as mentioned above.
Referring to Fig. 4, in another embodiment, rather than parallel co-knitting, stent 60 is formed by continuous knitting of a first strand 62, preferably a metal such as tantalum and a second strand 64 such as dacron in alternating regions, to perform specific functions. Metal strand 62 in the end regions provide anchoring portions while textile strand 64 provides a patent graft region.
Referring to Figs. 5-5c, in another embodiment, rather than parallel co-knitting, a graft 70 is provided that is formed of a first, separately knitted tubular structure 72 formed of a first strand 73, e.g. tantalum, and a second separately tubular knitted structure 74, assembled coaxially within the first structure 72 and formed of a second strand 75, e.g. dacron. At the ends 76, 76', the second tubular knit structure 74 is rolled over the outside of the first knit structure to form a cuff, to secure the assembly together. The first and second tubular knit structures may also be secured by sewing them together. In an alternative construction, the second tubular knitted structure of dacron could be a continuously co-knitted extension of the first metal tubular structure and the dacron knitted structure is pulled through the center of the metal structure. In other embodiments, the fabric knitted structure is on the outside of the metal knitted structure or is sandwiched between two metal structures or the metal knitted structure is between two fabric knitted structures. In another embodiment two tubular members can be effectively formed as a double knit structure.
In the embodiments of the invention discussed in the above description, the prostheses are formed of knitted strands, in other embodiments, other methods of forming a tubular structure from strands such as co- weaving, co-crocheting and the like can also be used. In some cases, with knitted embodiments or otherwise, it may be desireable to use a velour which is a variant of knitted material in which loops of yarn extend outward from the surface of the fabric formed by the knit structure. Manufacture
Tubular prostheses of the invention may be manufactured on a circular knitting apparatus. Referring to Figs. 6-6e, knitting apparatus are diagrammatically shown. Referring to Fig. 6, the apparatus includes a knitting head 92 for guiding a series of needles 94, 94' which are axially extended and retracted by a rotating (arrow 95) contoured platen 96. Spools 98, 98 ' feed strand material to the needles during the knitting operation. The knit structure 101 is produced around a plastic mandrel 100 which is drawn downward in the direction of arrow 102.
Referring particularly to Figs. 6a-6d, the needles, such as needle 94, include a needle head 106 and a pivoted needle tongue 108. During the upstroke of the needle, the head 106 grasps a feed from the strand spool 98, the tongue 108 being initially in the downward position (Fig. 6a) . On the downstroke, the tongue 108 is deflected upward as it engages the portion of the knitting head 94, thus enclosing the strand within the head (Fig. 6b) . The downstroke continues for a selected length within the knitting head (Fig. 6c) . On the upstroke, the strand deflects the tongue 108 downward, thus releasing the strand from the needle head 106 (Fig. 6d) . The cycle is repeated as the platen 96 rotates.
The contour of the platen is selected to drive the needles for forming a desired knit pattern. In the embodiment in Fig. 6, needles 94, 94' disposed about the needle head 92 at 180° are synchronized to simultaneously pass through the stroke cycle by platen 96 which is contoured symmetrically with opposed raised sections 99, 99' and intervening valleys. By providing different strands on spools 98, 98', the knit pattern will be a continuous alternating tubular knit structure 101 such as that described with respect to Fig. 3, above.
For forming parallel co-knit structures, multiple strands are passed through each needle head to cause simultaneous parallel co-knitting. Referring to Fig. 6e, the circular knitting machine is shown configured for parallel co-knitting by providing strands from spools
110, 110', 112, 112' so that needles 94, 94' are provided simultaneously with multiple strands of different materials. A platen 118 is provided which has a single raised section 120 to sequentially drive each needle about the periphery of the knitting head through the stroke cycle. The parallel co-knit structure 103 is formed on mandrel 100. Co-knitting may be ceased by providing only a single strand to the needle heads, for example when knitting a graft such as in Fig. 1, with a co-knit wall portion and integral single knit anchoring end portions.
Generally, the number of needles circumferentially disposed around the knitting head determines the number of circumferential knit loops. The size of the needle affects the narrowness of the loops; a smaller needle forms a narrower loop since the strand bends more acutely around the narrower needle head. The diameter of the knitting head affects the diameter of the knitted stent. Delivery
The prostheses of the invention can be positioned by various means. For example, for a balloon expandable graft with balloon expandable anchoring end portions, the graft may be positioned using a catheter with a balloon having a length substantially the length of the graft and an inflated diameter sufficient to expand the graft to the desired maximum size and to smaller sizes by partial inflation. For a graft which has a self- expanding wall portion and self-expanding anchoring ends, the graft can be restrained to small size on a catheter with a constraint such as a sleeve which is removed to release the stent at the placement site. These self- expanding grafts may be wrapped around a distal portion of the catheter in a 'jelly roll' fashion. Referring to Figs. 7-7d, positioning of a graft having self-expanding anchoring ends and a balloon expandable wall portion is illustrated. The graft 80 is positioned at the distal end of a catheter 30 which includes an inflatable balloon 32 upon which the graft is placed and an axially slidable sleeve member 34 which is placed over the graft 80 to constrain the self-expanding anchoring ends 82, 82' and a balloon wall portion formed of a co-knit tubular structure including a clot-inducing strand and a metal strand. The catheter 30, which for introduction through a vessel such as the iliac artery 36 has a diameter of about 20 French, is advanced to the aorta 38 that has been weakened by an aneurysm 40. The catheter 30 positions the graft such that graft 80 spans the region effected by aneurysm 40 and axially therebeyond to portions 42, 44 of the aorta that remain healthy but such that the graft will not interfere with the renal arteries 41. In.case of an approach through the femoral artery a smaller catheter (about 12 F) is used. In this latter case,"the stent is constructed with a 5 to 1 ratio of expanded to compressed size. Placement of the graft should be accurate to within about +/- 0.5 cm to properly position the anchoring ends 80, 80' which are typically about:A.5 cm in length on the healthy portions of~the aorta. Referring to-Fig. 7a, the graft 80 is placed in the lumen by withdrawing the sleeve 34 axially (arrow 46) which releases the restraint on end portion 82' causing it to expand to engage the inner wall of the healthy portion 44 of the aorta. Referring to Fig. 7b, with sleeve 34 completely removed from the prosthesis the anchoring end 82 similarly expands to engage the healthy portion 42 of the aorta, thus fixing the prosthesis in the lumen and positioning the wall portion 84, which remains unexpanded, at the location of the aneurysm 40.
Referring to Fig. 7c, a view in partial cross section, the balloon 32 is inflated to produce a radial force (arrow 48) which expands the wall portion 84 to a desired diameter that approximates the diameter of the healthy portions of the aorta such that the wall portion of the graft does not engage the weakened tissue of the aneurysm.
Referring to Fig. 7d, after expansion of the wall portion 84, the balloon 32 can be deflated and the catheter removed from the lumen, leaving the prosthesis 80 positioned across the aneurysm and securely anchored. As discussed above, clotting is induced by a non-metallic textured strand of the graft to fill the interstices between adjacent knitted loops within a reasonable time to form a patent covering over the wall portion of the graft.
Still other embodiments are within the following claims.
What is claimed is:

Claims

1. A tubular prosthesis comprising: a tubular wall portion of loosely interlocked knitted loops constructed to function within a body lumen, said loops being formed of co-knitted strand materials wherein a first strand material of said loops is a metal wire that structurally defines the tubular shape of said prosthesis and maintains said shape when positioned in said lumen and a second strand material of said loops, co-knitted with said metallic strand and comprising a predetermined substance selected to provide desired characteristics to the wall of said prosthesis.
2. A vascular graft prosthesis for bridging an aneurysm in an arterial lumen of the body comprising: a tubular wall portion of loosely interlocked knitted loops constructed to function within said arterial lumen, said loops being formed of co-knitted strand materials wherein a first strand material of said loops is a metal wire that structurally defines the tubular shape of said prosthesis and maintains said shape when positioned in said lumen and a second strand material of said loops, co-knitted with said metallic strand, comprises a predetermined non-metallic substance selected to provide desired characteristics to the wall of said prosthesis to enable it to perform its said function to effectively provide a patent covering over the structure of said graft.
3. The prosthesis of claim 1 or 2 including an anchoring end portion of knitted loops, knitted integrally with at least a portion of said co-knitted wall portion and formed of a strand material adapted to make contact with the wall of said body lumen to maintain the axial position of said prosthesis in said body lumen.
4. The prosthesis of claim 3 wherein said anchoring end portion is formed of contiguous loops of said first, metal strand material joined integrally with the said wall portion that includes said co-knit second strand.
5. The prosthesis of claim 1 or 2 wherein an anchoring end portion of said prosthesis is self- expanding, being formed of elastic metal strand capable of being reduced in radial size without plastic deformation and retaining self-restoring capability, whereby said end portion can be reduced to a relatively small size for introduction lengthwise into said lumen, and when freed can radially self-expand to tubular form to engage the wall of said lumen.
6. The prosthesis of claim 5 wherein said wall portion is expandable to desired size by means of an internal expanding force.
7. The prosthesis of claim 1 or 2 wherein said wall portion is expandable to a desired size by means of an internal expanding force.
8. The prosthesis of claim 7 wherein said first strand material of said wall portion is a plastically deformable metal, said wall portion being expandable to a desired size by application of an internal expanding force.
9. This prosthesis of claim 8 having an anchoring end portion formed of said plastically deformable metal and is knit integrally with said wall portion.
10. The prosthesis of claim 1 or 2 having an anchoring end portion formed of metal strand flared to a diameter greater than the wall portion.
11. The prosthesis of claim 1 or 2 including an anchoring portion at each of its axial ends.
12. The prosthesis of claim 1 or 2 wherein said first strand is selected from the group consisting of tantalum and nitinol.
13. The prosthesis of claim 12 wherein said second strand is selected from the group consisting of dacron, wool, nylon, polyethylene and teflon.
14. The prosthesis of claim 1 or 2 wherein the material of said second strand is textured to induce blood clotting.
15. The prosthesis of claim 14 wherein said prosthesis is sized for use as an aortic graft.
16. The prosthesis of claim 15 wherein said graft has a porosity of about 4000 ml/ in or more at implantation.
17. The prosthesis of claim 1 or 2 wherein said wall portion includes a highly elastic strand and is self-expanding.
18. The prosthesis of claim 1 wherein said second strand is formed of a body fluid-dissolvable suture material.
19. The prosthesis of claim 1 or 2 wherein said second strand is an absorbing member that includes a drug.
20. The prosthesis of claim 1 or 2 wherein said co-knit strands are in a parallel co-knit pattern.
21. A vascular prosthesis for use in an arterial lumen of the body comprising: a tubular wall portion of loosely interlocked knitted loops constructed to function within said arterial lumen, said loops being formed of parallel co- knitted strand materials wherein a first strand material of said loops is a metal wire that structurally defines the tubular shape of said prosthesis and maintains said shape when positioned in said lumen and a second strand material of said loops, co-knitted with said metallic strand and comprising a textured textile strand substance selected to enhance patency characteristics of the wall of said prosthesis.
22. The prosthesis of claim 21 wherein said wall portion is expandable to a desired size by means of an internal expanding force.
23. The prosthesis of claim 22 wherein said first strand material of said wall portion is a plastically deformable metal, said wall portion being expandable to a desired size by application of an internal expanding force.
24. The prosthesis of claim 23 having an anchoring end portion formed of said plastically deformable metal and knit integrally with said wall portion.
25. A tubular prosthesis comprising: a tubular wall portion of loosely interlocked knitted loops constructed to function within a body lumen, said loops being formed of multiple strand materials wherein a first strand material of said loops is a metal wire that structurally defines the tubular shape of said prosthesis and maintains said shape when positioned in said lumen and a second strand material of knitted loops, which comprises a predetermined substance selected to provide desired characteristics to the wall of said prosthesis.
26. The prosthesis of claim 25 wherein said first strand material and second strand material are continuously, single knitted to form regions of said tubular knit structure formed of said first material and regions of said knit structure formed of said second material.
27. The prosthesis of claim 26 wherein said first and second strand materials are alternately knitted to form successive alternating loop rows of said first and second material.
28. The prosthesis of claim 27 wherein said second strand is formed of a body fluid-dissolvable suture material.
29. The prosthesis of claim 28 wherein said second strand is an absorbing member that includes a drug.
30. The prosthesis of claim 25 or 27 wherein said second strand material is a metal.
31. The prosthesis of claim 30 wherein said second strand material is a dense metal that enhances the radiopacity of said prosthesis.
32. The prosthesis of claim 25 wherein said first and second strand materials are formed as separate knitted loop tubular structures and said second strand knitted loop structure extends coaxially with said first strand knitted loop structure, and extends over an end of said first strand knitted loop structure to form a cuff to secure said first knitted structure to said second knitted structure.
33. A tubular prosthesis comprising: a tubular wall portion of a loosely interlocked regular pattern of strands constructed to function within a body lumen, said pattern being formed of multiple strand materials wherein a first strand material of said pattern is a metal wire that structurally defines the tubular shape of said prosthesis and maintains said shape when positioned in said lumen and a second strand material of said pattern, integrated with said metallic strand as part of said pattern, which comprises a predetermined substance selected to provide desired characteristics to the wall of said prosthesis.
34. The tubular prosthesis of claim 33 wherein said pattern is formed by co-weaving or co-crocheting said strands.
35. The tubular prosthesis of claim 34 wherein said pattern is formed of multiple parallel strands.
PCT/US1993/006529 1992-07-13 1993-07-12 Tubular medical prosthesis WO1994001056A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE69332800T DE69332800T2 (en) 1992-07-13 1993-07-12 TUBULAR MEDICAL PROSTHESIS
JP6503559A JPH07509152A (en) 1992-07-13 1993-07-12 tubular medical prosthesis
CA002139564A CA2139564C (en) 1992-07-13 1993-07-12 Tubular medical prosthesis
EP93917107A EP0651624B1 (en) 1992-07-13 1993-07-12 Tubular medical prosthesis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/912,902 US5366504A (en) 1992-05-20 1992-07-13 Tubular medical prosthesis
US07/912,902 1992-07-13

Publications (1)

Publication Number Publication Date
WO1994001056A1 true WO1994001056A1 (en) 1994-01-20

Family

ID=25432664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/006529 WO1994001056A1 (en) 1992-07-13 1993-07-12 Tubular medical prosthesis

Country Status (6)

Country Link
US (3) US5366504A (en)
EP (1) EP0651624B1 (en)
JP (1) JPH07509152A (en)
CA (1) CA2139564C (en)
DE (1) DE69332800T2 (en)
WO (1) WO1994001056A1 (en)

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689806A2 (en) * 1994-06-28 1996-01-03 Meadox Medicals, Inc. Implantable tubular prosthesis having cuffs
EP0757571A1 (en) * 1994-04-28 1997-02-12 Boston Scientific Corporation Placement of endoprostheses and stents
EP0761251A1 (en) * 1994-10-17 1997-03-12 Kabushikikaisha Igaki Iryo Sekkei Drug-releasing stent
WO1997013475A1 (en) * 1995-10-11 1997-04-17 Schneider (Usa) Inc. Braided composite prosthesis
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5639278A (en) * 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US5653747A (en) * 1992-12-21 1997-08-05 Corvita Corporation Luminal graft endoprostheses and manufacture thereof
EP0804909A2 (en) * 1996-04-30 1997-11-05 Schneider (Usa) Inc. Three dimensional braided covered stent
US5723004A (en) * 1993-10-21 1998-03-03 Corvita Corporation Expandable supportive endoluminal grafts
US5733325A (en) * 1993-11-04 1998-03-31 C. R. Bard, Inc. Non-migrating vascular prosthesis and minimally invasive placement system
WO1998019629A2 (en) * 1996-11-07 1998-05-14 Vascular Science Inc. Medical grafting connectors and fasteners
WO1998019636A2 (en) * 1996-11-07 1998-05-14 Vascular Science Inc. Medical grafting methods and apparatus
US5855598A (en) * 1993-10-21 1999-01-05 Corvita Corporation Expandable supportive branched endoluminal grafts
EP0916362A1 (en) * 1997-03-31 1999-05-19 Kabushikikaisha Igaki Iryo Sekkei Stent for vessels
US5980972A (en) * 1996-12-20 1999-11-09 Schneider (Usa) Inc Method of applying drug-release coatings
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US6098630A (en) * 1994-06-13 2000-08-08 Endomed Inc. Multiple diameter expandable graft for blood vessel and method for deploying the same
US6113612A (en) * 1998-11-06 2000-09-05 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US6120536A (en) * 1995-04-19 2000-09-19 Schneider (Usa) Inc. Medical devices with long term non-thrombogenic coatings
US6152937A (en) * 1998-11-06 2000-11-28 St. Jude Medical Cardiovascular Group, Inc. Medical graft connector and methods of making and installing same
WO2001056499A1 (en) 2000-01-31 2001-08-09 Ethicon Gmbh Areal implant with x-ray-visible elements
WO2002022049A2 (en) 2000-09-12 2002-03-21 Georgios Archodoulakis Implantable prosthesis for intravascular applications
GB2378137A (en) * 2001-07-31 2003-02-05 John Reece Jenkins A stent comprising a framework of shape memory metal
US6554858B2 (en) 1996-04-25 2003-04-29 Corvita Europe Intraluminal endoprosthesis for ramifying the ducts of a human or animal body and method of manufacture thereof
EP1308138A3 (en) * 2001-10-30 2003-07-30 Olympus Optical Co., Ltd. Stent
US6602263B1 (en) 1999-11-30 2003-08-05 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6620190B1 (en) 1994-05-06 2003-09-16 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Radially expandable polytetrafluoroethylene
EP1343435A2 (en) * 2000-10-31 2003-09-17 Prodesco , Inc. Graft having region for biological seal formation
US6660015B1 (en) 1998-01-30 2003-12-09 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
US6712836B1 (en) 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
DE102004008459A1 (en) * 2004-02-17 2005-09-01 Aesculap Ag & Co. Kg Implant, useful as stents, comprises a fabric and at least a radiopaque marker, which passes in a direction along the implant
US6994713B2 (en) 1998-01-30 2006-02-07 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
EP1769774A1 (en) * 2005-10-03 2007-04-04 Noureddine Frid Radiopaque endoprostheses
US7306625B1 (en) 1999-06-24 2007-12-11 Abbott Laboratories Balloon expandable stent
US7413540B2 (en) 1997-02-13 2008-08-19 Boston Scientific Scimed, Inc. Devices for minimally invasive pelvic surgery
US7465483B2 (en) 1994-06-27 2008-12-16 C.R.Bard Inc. Radially expandable polytetrafluoroethylene
EP2103277A3 (en) * 1994-10-18 2010-01-20 TERAMed Corporation Apparatus for deploying stents
US7691128B2 (en) 2002-05-06 2010-04-06 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
US7717937B2 (en) 2001-06-01 2010-05-18 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US8114102B2 (en) 2003-06-16 2012-02-14 St. Jude Medical Atg, Inc. Temporary hemostatic plug apparatus and method of use
US8182527B2 (en) 2001-05-07 2012-05-22 Cordis Corporation Heparin barrier coating for controlled drug release
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US8303609B2 (en) 2000-09-29 2012-11-06 Cordis Corporation Coated medical devices
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
FR2989567A1 (en) * 2012-04-23 2013-10-25 St George Medical Inc ENDOLUMINAL VASCULAR PROSTHESIS FOR SMALL VESSELS
US8574264B2 (en) 2003-04-11 2013-11-05 St. Jude Medical, Cardiology Division, Inc. Method for retrieving a closure device
EP1455687B1 (en) * 2001-12-19 2014-09-10 Cook Medical Technologies LLC Stent graft with improved graft adhesion
EP2512369A4 (en) * 2009-12-16 2015-11-25 Neograft Technologies Inc Graft devices and methods of use
EP3569192A1 (en) * 2015-01-16 2019-11-20 Boston Scientific Scimed, Inc. Implantable medical device with reduced migration capabilities
WO2021083505A1 (en) * 2019-10-30 2021-05-06 Angiomed Gmbh & Co. Medizintechnik Kg Tips stent graft and kit

Families Citing this family (529)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545208A (en) * 1990-02-28 1996-08-13 Medtronic, Inc. Intralumenal drug eluting prosthesis
US6004346A (en) * 1990-02-28 1999-12-21 Medtronic, Inc. Intralumenal drug eluting prosthesis
DE4122923C1 (en) * 1991-07-11 1993-01-28 Willy Ruesch Ag, 7053 Kernen, De
US5366504A (en) * 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US6497709B1 (en) 1992-03-31 2002-12-24 Boston Scientific Corporation Metal medical device
JPH07505316A (en) 1992-03-31 1995-06-15 ボストン サイエンティフィック コーポレーション medical wire
US5630840A (en) 1993-01-19 1997-05-20 Schneider (Usa) Inc Clad composite stent
US20020055710A1 (en) 1998-04-30 2002-05-09 Ronald J. Tuch Medical device for delivering a therapeutic agent and method of preparation
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
WO1995008966A1 (en) 1993-09-30 1995-04-06 White Geoffrey H Intraluminal graft
US6685736B1 (en) 1993-09-30 2004-02-03 Endogad Research Pty Limited Intraluminal graft
WO1995009586A1 (en) * 1993-10-01 1995-04-13 Emory University Self-expanding intraluminal composite prosthesis
US5527353A (en) * 1993-12-02 1996-06-18 Meadox Medicals, Inc. Implantable tubular prosthesis
US5609627A (en) * 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US6051020A (en) 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US6165213A (en) * 1994-02-09 2000-12-26 Boston Scientific Technology, Inc. System and method for assembling an endoluminal prosthesis
US6039749A (en) 1994-02-10 2000-03-21 Endovascular Systems, Inc. Method and apparatus for deploying non-circular stents and graftstent complexes
US5653746A (en) * 1994-03-08 1997-08-05 Meadox Medicals, Inc. Radially expandable tubular prosthesis
EP0759730B1 (en) 1994-05-19 1999-02-10 Scimed Life Systems, Inc. Improved tissue supporting devices
EP0792627B2 (en) 1994-06-08 2003-10-29 Cardiovascular Concepts, Inc. System for forming a bifurcated graft
US6331188B1 (en) 1994-08-31 2001-12-18 Gore Enterprise Holdings, Inc. Exterior supported self-expanding stent-graft
US6015429A (en) 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
US5755770A (en) 1995-01-31 1998-05-26 Boston Scientific Corporatiion Endovascular aortic graft
US6264684B1 (en) 1995-03-10 2001-07-24 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Helically supported graft
US6451047B2 (en) 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
EP0734698B9 (en) * 1995-04-01 2006-07-05 Variomed AG Stent for transluminal implantation into hollow organs
US5591199A (en) * 1995-06-07 1997-01-07 Porter; Christopher H. Curable fiber composite stent and delivery system
RU2157146C2 (en) * 1995-06-13 2000-10-10 ВИЛЬЯМ КУК Европа, A/S Device for performing implantation in blood vessels and hollow organs
US5569273A (en) * 1995-07-13 1996-10-29 C. R. Bard, Inc. Surgical mesh fabric
US6193745B1 (en) * 1995-10-03 2001-02-27 Medtronic, Inc. Modular intraluminal prosteheses construction and methods
US5824037A (en) * 1995-10-03 1998-10-20 Medtronic, Inc. Modular intraluminal prostheses construction and methods
US6099558A (en) * 1995-10-10 2000-08-08 Edwards Lifesciences Corp. Intraluminal grafting of a bifuricated artery
US6689162B1 (en) * 1995-10-11 2004-02-10 Boston Scientific Scimed, Inc. Braided composite prosthesis
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US5913896A (en) * 1995-11-28 1999-06-22 Medtronic, Inc. Interwoven dual sinusoidal helix stent
US6576009B2 (en) * 1995-12-01 2003-06-10 Medtronic Ave, Inc. Bifurcated intraluminal prostheses construction and methods
US5824040A (en) * 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
EP0866677A4 (en) 1995-12-14 1999-10-27 Prograft Medical Inc Stent-graft deployment apparatus and method
US6042605A (en) 1995-12-14 2000-03-28 Gore Enterprose Holdings, Inc. Kink resistant stent-graft
DE69735530T2 (en) * 1996-01-04 2006-08-17 Chuter, Timothy A.M. Dr., Atherton FLAT WIRE STENT
US6719782B1 (en) 1996-01-04 2004-04-13 Endovascular Technologies, Inc. Flat wire stent
US5725547A (en) * 1996-01-04 1998-03-10 Chuter; Timothy A. M. Corrugated stent
US5895406A (en) * 1996-01-26 1999-04-20 Cordis Corporation Axially flexible stent
US5980553A (en) * 1996-12-20 1999-11-09 Cordis Corporation Axially flexible stent
US6258116B1 (en) 1996-01-26 2001-07-10 Cordis Corporation Bifurcated axially flexible stent
US5938682A (en) * 1996-01-26 1999-08-17 Cordis Corporation Axially flexible stent
US5749921A (en) * 1996-02-20 1998-05-12 Medtronic, Inc. Apparatus and methods for compression of endoluminal prostheses
US6019784A (en) * 1996-04-04 2000-02-01 Electroformed Stents, Inc. Process for making electroformed stents
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
US5833699A (en) * 1996-04-10 1998-11-10 Chuter; Timothy A. M. Extending ribbon stent
NZ331269A (en) * 1996-04-10 2000-01-28 Advanced Cardiovascular System Expandable stent, its structural strength varying along its length
US5843161A (en) * 1996-06-26 1998-12-01 Cordis Corporation Endoprosthesis assembly for percutaneous deployment and method of deploying same
US5968068A (en) * 1996-09-12 1999-10-19 Baxter International Inc. Endovascular delivery system
EP0934035B8 (en) 1996-09-26 2006-01-18 Boston Scientific Scimed, Inc. Support structure/membrane composite medical device
US5824046A (en) * 1996-09-27 1998-10-20 Scimed Life Systems, Inc. Covered stent
EP0944366B1 (en) * 1996-11-04 2006-09-13 Advanced Stent Technologies, Inc. Extendible double stent
US5941908A (en) * 1997-04-23 1999-08-24 Vascular Science, Inc. Artificial medical graft with a releasable retainer
US5860998A (en) * 1996-11-25 1999-01-19 C. R. Bard, Inc. Deployment device for tubular expandable prosthesis
US6551350B1 (en) 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
US6352561B1 (en) 1996-12-23 2002-03-05 W. L. Gore & Associates Implant deployment apparatus
US5961545A (en) * 1997-01-17 1999-10-05 Meadox Medicals, Inc. EPTFE graft-stent composite device
US5843166A (en) * 1997-01-17 1998-12-01 Meadox Medicals, Inc. Composite graft-stent having pockets for accomodating movement
US6241757B1 (en) * 1997-02-04 2001-06-05 Solco Surgical Instrument Co., Ltd. Stent for expanding body's lumen
US6951572B1 (en) 1997-02-20 2005-10-04 Endologix, Inc. Bifurcated vascular graft and method and apparatus for deploying same
US6090128A (en) * 1997-02-20 2000-07-18 Endologix, Inc. Bifurcated vascular graft deployment device
ATE287679T1 (en) * 1997-03-05 2005-02-15 Boston Scient Ltd COMPLIANT MULTI-LAYER STENT DEVICE
US5843168A (en) * 1997-03-31 1998-12-01 Medtronic, Inc. Double wave stent with strut
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US5980564A (en) * 1997-08-01 1999-11-09 Schneider (Usa) Inc. Bioabsorbable implantable endoprosthesis with reservoir
US6245103B1 (en) 1997-08-01 2001-06-12 Schneider (Usa) Inc Bioabsorbable self-expanding stent
US6340367B1 (en) 1997-08-01 2002-01-22 Boston Scientific Scimed, Inc. Radiopaque markers and methods of using the same
US6070589A (en) 1997-08-01 2000-06-06 Teramed, Inc. Methods for deploying bypass graft stents
US6746476B1 (en) * 1997-09-22 2004-06-08 Cordis Corporation Bifurcated axially flexible stent
US6186985B1 (en) 1997-10-03 2001-02-13 Boston Scientific Corporation Gastro-intestinal tube with dissolvable support bolster
US6371982B2 (en) 1997-10-09 2002-04-16 St. Jude Medical Cardiovascular Group, Inc. Graft structures with compliance gradients
US6161399A (en) * 1997-10-24 2000-12-19 Iowa-India Investments Company Limited Process for manufacturing a wire reinforced monolayer fabric stent
US6626939B1 (en) * 1997-12-18 2003-09-30 Boston Scientific Scimed, Inc. Stent-graft with bioabsorbable structural support
US6048362A (en) * 1998-01-12 2000-04-11 St. Jude Medical Cardiovascular Group, Inc. Fluoroscopically-visible flexible graft structures
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6015432A (en) * 1998-02-25 2000-01-18 Cordis Corporation Wire reinforced vascular prosthesis
US6235054B1 (en) 1998-02-27 2001-05-22 St. Jude Medical Cardiovascular Group, Inc. Grafts with suture connectors
US6077296A (en) 1998-03-04 2000-06-20 Endologix, Inc. Endoluminal vascular prosthesis
US6290731B1 (en) 1998-03-30 2001-09-18 Cordis Corporation Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm
US6656215B1 (en) 2000-11-16 2003-12-02 Cordis Corporation Stent graft having an improved means for attaching a stent to a graft
US6264689B1 (en) * 1998-03-31 2001-07-24 Scimed Life Systems, Incorporated Low profile medical stent
US6520983B1 (en) * 1998-03-31 2003-02-18 Scimed Life Systems, Inc. Stent delivery system
US7713297B2 (en) * 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US20020099438A1 (en) 1998-04-15 2002-07-25 Furst Joseph G. Irradiated stent coating
US20030040790A1 (en) * 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US8029561B1 (en) 2000-05-12 2011-10-04 Cordis Corporation Drug combination useful for prevention of restenosis
US6494907B1 (en) 1998-04-28 2002-12-17 Intratherapeutics, Inc. Braided stent
US6740113B2 (en) * 1998-05-29 2004-05-25 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
US6168621B1 (en) * 1998-05-29 2001-01-02 Scimed Life Systems, Inc. Balloon expandable stent with a self-expanding portion
AU4679499A (en) * 1998-06-10 1999-12-30 Advanced Bypass Technologies, Inc. Thermal securing anastomosis systems
US7815626B1 (en) 1998-06-12 2010-10-19 Target Therapeutics, Inc. Catheter with knit section
US6224627B1 (en) 1998-06-15 2001-05-01 Gore Enterprise Holdings, Inc. Remotely removable covering and support
JP4377546B2 (en) 1998-06-19 2009-12-02 エンドロジックス、インク Self-expanding branch lumen prosthesis
US7967855B2 (en) * 1998-07-27 2011-06-28 Icon Interventional Systems, Inc. Coated medical device
US8070796B2 (en) * 1998-07-27 2011-12-06 Icon Interventional Systems, Inc. Thrombosis inhibiting graft
US7004962B2 (en) * 1998-07-27 2006-02-28 Schneider (Usa), Inc. Neuroaneurysm occlusion and delivery device and method of using same
US6093199A (en) * 1998-08-05 2000-07-25 Endovascular Technologies, Inc. Intra-luminal device for treatment of body cavities and lumens and method of use
US6143022A (en) * 1998-08-24 2000-11-07 Medtronic Ave, Inc. Stent-graft assembly with dual configuration graft component and method of manufacture
US6340368B1 (en) 1998-10-23 2002-01-22 Medtronic Inc. Implantable device with radiopaque ends
US6508252B1 (en) 1998-11-06 2003-01-21 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6475222B1 (en) 1998-11-06 2002-11-05 St. Jude Medical Atg, Inc. Minimally invasive revascularization apparatus and methods
US6190403B1 (en) 1998-11-13 2001-02-20 Cordis Corporation Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity
US6322585B1 (en) * 1998-11-16 2001-11-27 Endotex Interventional Systems, Inc. Coiled-sheet stent-graft with slidable exo-skeleton
US6325820B1 (en) 1998-11-16 2001-12-04 Endotex Interventional Systems, Inc. Coiled-sheet stent-graft with exo-skeleton
JP4189127B2 (en) 1998-12-11 2008-12-03 エンドロジックス、インク Intraluminal artificial blood vessels
US6660030B2 (en) 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
US6197049B1 (en) 1999-02-17 2001-03-06 Endologix, Inc. Articulating bifurcation graft
US6733523B2 (en) 1998-12-11 2004-05-11 Endologix, Inc. Implantable vascular graft
US6187036B1 (en) 1998-12-11 2001-02-13 Endologix, Inc. Endoluminal vascular prosthesis
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6398803B1 (en) 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6274294B1 (en) 1999-02-03 2001-08-14 Electroformed Stents, Inc. Cylindrical photolithography exposure process and apparatus
US6361557B1 (en) 1999-02-05 2002-03-26 Medtronic Ave, Inc. Staplebutton radiopaque marker
WO2000053104A1 (en) 1999-03-09 2000-09-14 St. Jude Medical Cardiovascular Group, Inc. Medical grafting methods and apparatus
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US6287333B1 (en) 1999-03-15 2001-09-11 Angiodynamics, Inc. Flexible stent
US6273911B1 (en) 1999-04-22 2001-08-14 Advanced Cardiovascular Systems, Inc. Variable strength stent
US6287335B1 (en) * 1999-04-26 2001-09-11 William J. Drasler Intravascular folded tubular endoprosthesis
BR9901540C1 (en) * 1999-05-17 2001-12-18 Fundacao Zerbini Device for unblocking atherosclerotic lesions that include the origin of lateral branches or located in bifurcations of the coronary circulation, and the respective intervention process for placing the referred device
US6699256B1 (en) 1999-06-04 2004-03-02 St. Jude Medical Atg, Inc. Medical grafting apparatus and methods
US7462162B2 (en) * 2001-09-04 2008-12-09 Broncus Technologies, Inc. Antiproliferative devices for maintaining patency of surgically created channels in a body organ
US7815590B2 (en) 1999-08-05 2010-10-19 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
FR2797389B1 (en) * 1999-08-09 2001-11-30 Novatech Inc BIFURCED AORTIC PROSTHESIS
US6540774B1 (en) 1999-08-31 2003-04-01 Advanced Cardiovascular Systems, Inc. Stent design with end rings having enhanced strength and radiopacity
US6344056B1 (en) 1999-12-29 2002-02-05 Edwards Lifesciences Corp. Vascular grafts for bridging a vessel side branch
DE19951477A1 (en) * 1999-10-26 2001-05-03 Biotronik Mess & Therapieg Stent
US6475235B1 (en) 1999-11-16 2002-11-05 Iowa-India Investments Company, Limited Encapsulated stent preform
US6663667B2 (en) 1999-12-29 2003-12-16 Edwards Lifesciences Corporation Towel graft means for enhancing tissue ingrowth in vascular grafts
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20030114918A1 (en) * 2000-04-28 2003-06-19 Garrison Michi E. Stent graft assembly and method
US6652576B1 (en) 2000-06-07 2003-11-25 Advanced Cardiovascular Systems, Inc. Variable stiffness stent
US7632303B1 (en) 2000-06-07 2009-12-15 Advanced Cardiovascular Systems, Inc. Variable stiffness medical devices
US6652579B1 (en) 2000-06-22 2003-11-25 Advanced Cardiovascular Systems, Inc. Radiopaque stent
US6540775B1 (en) * 2000-06-30 2003-04-01 Cordis Corporation Ultraflexible open cell stent
US6699278B2 (en) 2000-09-22 2004-03-02 Cordis Corporation Stent with optimal strength and radiopacity characteristics
US6652574B1 (en) 2000-09-28 2003-11-25 Vascular Concepts Holdings Limited Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer
US6547820B1 (en) * 2000-10-03 2003-04-15 Scimed Life Systems, Inc. High profile fabric graft for arteriovenous access
US20020087176A1 (en) * 2000-10-10 2002-07-04 Greenhalgh E. Skott Anastomosis device
WO2003061502A1 (en) 2000-10-26 2003-07-31 Scimed Life Systems, Inc. Stent having radiopaque markers and method of fabricating the same
US20040018228A1 (en) * 2000-11-06 2004-01-29 Afmedica, Inc. Compositions and methods for reducing scar tissue formation
US6534693B2 (en) * 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US20040241211A9 (en) * 2000-11-06 2004-12-02 Fischell Robert E. Devices and methods for reducing scar tissue formation
US20020124851A1 (en) * 2000-11-28 2002-09-12 Richard Knauer Hearing protective device and method of making same
US6547812B1 (en) 2000-12-29 2003-04-15 Advanced Cardiovascular Systems, Inc. Radiation therapy using a radioactive implantable device and a radiosensitizer agent
US6699274B2 (en) * 2001-01-22 2004-03-02 Scimed Life Systems, Inc. Stent delivery system and method of manufacturing same
US20070168005A1 (en) * 2001-02-20 2007-07-19 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20070173911A1 (en) * 2001-02-20 2007-07-26 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050283214A1 (en) * 2003-08-25 2005-12-22 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US6783554B2 (en) * 2001-02-20 2004-08-31 Atrium Medical Corporation Pile mesh prosthesis
US20070168006A1 (en) * 2001-02-20 2007-07-19 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050288753A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050288750A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050283167A1 (en) * 2003-08-25 2005-12-22 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US6827743B2 (en) * 2001-02-28 2004-12-07 Sdgi Holdings, Inc. Woven orthopedic implants
US6790227B2 (en) 2001-03-01 2004-09-14 Cordis Corporation Flexible stent
US6679911B2 (en) 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US6955686B2 (en) 2001-03-01 2005-10-18 Cordis Corporation Flexible stent
AU784552B2 (en) 2001-03-02 2006-05-04 Cardinal Health 529, Llc Flexible stent
US6764505B1 (en) 2001-04-12 2004-07-20 Advanced Cardiovascular Systems, Inc. Variable surface area stent
US6620122B2 (en) * 2001-04-26 2003-09-16 Scimed Life Systems, Inc. Gastric pseudocyst drainage and stent delivery system for use therein
US7862495B2 (en) 2001-05-31 2011-01-04 Advanced Cardiovascular Systems, Inc. Radiation or drug delivery source with activity gradient to minimize edge effects
US6712844B2 (en) 2001-06-06 2004-03-30 Advanced Cardiovascular Systems, Inc. MRI compatible stent
AU2002345328A1 (en) 2001-06-27 2003-03-03 Remon Medical Technologies Ltd. Method and device for electrochemical formation of therapeutic species in vivo
US6656216B1 (en) 2001-06-29 2003-12-02 Advanced Cardiovascular Systems, Inc. Composite stent with regioselective material
US6605110B2 (en) 2001-06-29 2003-08-12 Advanced Cardiovascular Systems, Inc. Stent with enhanced bendability and flexibility
US8252040B2 (en) * 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US7708712B2 (en) * 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US7252679B2 (en) * 2001-09-13 2007-08-07 Cordis Corporation Stent with angulated struts
US20030055486A1 (en) * 2001-09-19 2003-03-20 Adams John M. Vascular reinforcement device and method
US7192441B2 (en) * 2001-10-16 2007-03-20 Scimed Life Systems, Inc. Aortic artery aneurysm endovascular prosthesis
US7033389B2 (en) * 2001-10-16 2006-04-25 Scimed Life Systems, Inc. Tubular prosthesis for external agent delivery
US20030077310A1 (en) 2001-10-22 2003-04-24 Chandrashekhar Pathak Stent coatings containing HMG-CoA reductase inhibitors
US8740973B2 (en) * 2001-10-26 2014-06-03 Icon Medical Corp. Polymer biodegradable medical device
NL1019316C2 (en) * 2001-11-06 2003-05-07 Tno A vascular prosthesis.
US6896665B2 (en) 2001-12-10 2005-05-24 Applied Medical Research Gastrostomy device package and method of assembly
WO2003053288A1 (en) 2001-12-20 2003-07-03 Trivascular, Inc. Advanced endovascular graft
US7147661B2 (en) 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US7029493B2 (en) 2002-01-25 2006-04-18 Cordis Corporation Stent with enhanced crossability
ATE425720T1 (en) * 2002-01-28 2009-04-15 Orbusneich Medical Inc EXPANDED OSTIUM ENDPROSTHESIS AND DELIVERY SYSTEM
US7008397B2 (en) * 2002-02-13 2006-03-07 Percardia, Inc. Cardiac implant and methods
GB0206061D0 (en) * 2002-03-14 2002-04-24 Angiomed Ag Metal structure compatible with MRI imaging, and method of manufacturing such a structure
US20040230288A1 (en) * 2002-04-17 2004-11-18 Rosenthal Arthur L. Medical devices adapted for controlled in vivo structural change after implantation
JP4265888B2 (en) * 2002-06-12 2009-05-20 株式会社リコー Image forming apparatus
US6656220B1 (en) 2002-06-17 2003-12-02 Advanced Cardiovascular Systems, Inc. Intravascular stent
US8016881B2 (en) 2002-07-31 2011-09-13 Icon Interventional Systems, Inc. Sutures and surgical staples for anastamoses, wound closures, and surgical closures
US7029495B2 (en) * 2002-08-28 2006-04-18 Scimed Life Systems, Inc. Medical devices and methods of making the same
US7011676B2 (en) * 2002-09-05 2006-03-14 Scimed Life Systems, Inc. Flat knitted stent and method of making the same
KR20050084599A (en) * 2002-09-26 2005-08-26 안지오테크 인터내셔날 아게 Perivascular wraps
US7485139B1 (en) 2002-10-10 2009-02-03 Ciamacco Jr Sam Stent delivery and deployment system
US7169178B1 (en) 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
US8449601B2 (en) * 2002-11-19 2013-05-28 Boston Scientific Scimed, Inc. Medical devices
FR2847155B1 (en) * 2002-11-20 2005-08-05 Younes Boudjemline METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY
US8105373B2 (en) 2002-12-16 2012-01-31 Boston Scientific Scimed, Inc. Flexible stent with improved axial strength
EP1432111A3 (en) * 2002-12-18 2006-04-12 Hephaist Seiko Co., Ltd. Control method and apparatus of an ultrasonic motor, and an ultrasonic motor driver and controller
US7494497B2 (en) 2003-01-02 2009-02-24 Boston Scientific Scimed, Inc. Medical devices
US7294214B2 (en) * 2003-01-08 2007-11-13 Scimed Life Systems, Inc. Medical devices
US20040143317A1 (en) * 2003-01-17 2004-07-22 Stinson Jonathan S. Medical devices
US20040148032A1 (en) * 2003-01-29 2004-07-29 Rutter Michael John Airway stent
US7025779B2 (en) * 2003-02-26 2006-04-11 Scimed Life Systems, Inc. Endoluminal device having enhanced affixation characteristics
US6908484B2 (en) * 2003-03-06 2005-06-21 Spinecore, Inc. Cervical disc replacement
US7487579B2 (en) * 2003-03-12 2009-02-10 Boston Scientific Scimed, Inc. Methods of making medical devices
US7792568B2 (en) * 2003-03-17 2010-09-07 Boston Scientific Scimed, Inc. MRI-visible medical devices
US7452374B2 (en) * 2003-04-24 2008-11-18 Maquet Cardiovascular, Llc AV grafts with rapid post-operative self-sealing capabilities
JP4692902B2 (en) 2003-04-28 2011-06-01 キップス・ベイ・メディカル・インコーポレーテッド Flexible vein graft
US20050131520A1 (en) * 2003-04-28 2005-06-16 Zilla Peter P. Compliant blood vessel graft
US7998188B2 (en) 2003-04-28 2011-08-16 Kips Bay Medical, Inc. Compliant blood vessel graft
US20040230289A1 (en) * 2003-05-15 2004-11-18 Scimed Life Systems, Inc. Sealable attachment of endovascular stent to graft
US20040230290A1 (en) * 2003-05-15 2004-11-18 Jan Weber Medical devices and methods of making the same
JP4081522B2 (en) * 2003-05-23 2008-04-30 新 石丸 Temporary indwelling stent and stent graft
WO2004110304A2 (en) * 2003-05-29 2004-12-23 Secor Medical, Llc Filament based prosthesis
US8002740B2 (en) 2003-07-18 2011-08-23 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US8308682B2 (en) 2003-07-18 2012-11-13 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US20050125036A1 (en) * 2003-08-14 2005-06-09 Mark Roby Heterogeneous yarns for surgical articles
US20100016891A1 (en) * 2003-08-14 2010-01-21 Kennedy John J Heterogeneous yarns for surgical articles
US20050050042A1 (en) * 2003-08-20 2005-03-03 Marvin Elder Natural language database querying
US20050049482A1 (en) * 2003-08-25 2005-03-03 Biophan Technologies, Inc. Electromagnetic radiation transparent device and method of making thereof
US8868212B2 (en) * 2003-08-25 2014-10-21 Medtronic, Inc. Medical device with an electrically conductive anti-antenna member
US20050288756A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050288752A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050283213A1 (en) * 2003-08-25 2005-12-22 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050288754A1 (en) * 2003-08-25 2005-12-29 Biophan Technologies, Inc. Medical device with an electrically conductive anti-antenna member
US20050060020A1 (en) * 2003-09-17 2005-03-17 Scimed Life Systems, Inc. Covered stent with biologically active material
US20050070990A1 (en) * 2003-09-26 2005-03-31 Stinson Jonathan S. Medical devices and methods of making same
US7198675B2 (en) 2003-09-30 2007-04-03 Advanced Cardiovascular Systems Stent mandrel fixture and method for selectively coating surfaces of a stent
US7056286B2 (en) 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
US8157855B2 (en) * 2003-12-05 2012-04-17 Boston Scientific Scimed, Inc. Detachable segment stent
US7854756B2 (en) * 2004-01-22 2010-12-21 Boston Scientific Scimed, Inc. Medical devices
US7632299B2 (en) 2004-01-22 2009-12-15 Boston Scientific Scimed, Inc. Medical devices
US7211108B2 (en) * 2004-01-23 2007-05-01 Icon Medical Corp. Vascular grafts with amphiphilic block copolymer coatings
US7803178B2 (en) 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
US8747453B2 (en) * 2008-02-18 2014-06-10 Aga Medical Corporation Stent/stent graft for reinforcement of vascular abnormalities and associated method
US7857767B2 (en) 2004-04-19 2010-12-28 Invention Science Fund I, Llc Lumen-traveling device
US7850676B2 (en) 2004-04-19 2010-12-14 The Invention Science Fund I, Llc System with a reservoir for perfusion management
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US8024036B2 (en) 2007-03-19 2011-09-20 The Invention Science Fund I, Llc Lumen-traveling biological interface device and method of use
US7998060B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling delivery device
US8337482B2 (en) 2004-04-19 2012-12-25 The Invention Science Fund I, Llc System for perfusion management
US8512219B2 (en) 2004-04-19 2013-08-20 The Invention Science Fund I, Llc Bioelectromagnetic interface system
US20070244520A1 (en) * 2004-04-19 2007-10-18 Searete Llc Lumen-traveling biological interface device and method of use
US8092549B2 (en) * 2004-09-24 2012-01-10 The Invention Science Fund I, Llc Ciliated stent-like-system
US8361013B2 (en) 2004-04-19 2013-01-29 The Invention Science Fund I, Llc Telescoping perfusion management system
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
AU2005237985B2 (en) 2004-04-20 2010-10-21 Genzyme Corporation Surgical mesh-like implant
US7682381B2 (en) * 2004-04-23 2010-03-23 Boston Scientific Scimed, Inc. Composite medical textile material and implantable devices made therefrom
US8048149B2 (en) * 2004-05-13 2011-11-01 Medtronic Vascular, Inc. Intraluminal stent including therapeutic agent delivery pads, and method of manufacturing the same
US20050260355A1 (en) * 2004-05-20 2005-11-24 Jan Weber Medical devices and methods of making the same
US20060100696A1 (en) 2004-11-10 2006-05-11 Atanasoska Ljiljana L Medical devices and methods of making the same
KR101300437B1 (en) 2004-05-25 2013-08-26 코비디엔 엘피 Vascular stenting for aneurysms
US8617234B2 (en) 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
US20060206200A1 (en) 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US8147534B2 (en) 2005-05-25 2012-04-03 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8267985B2 (en) * 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8628564B2 (en) 2004-05-25 2014-01-14 Covidien Lp Methods and apparatus for luminal stenting
AU2005247490B2 (en) 2004-05-25 2011-05-19 Covidien Lp Flexible vascular occluding device
US7585318B2 (en) * 2004-06-18 2009-09-08 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US7727271B2 (en) * 2004-06-24 2010-06-01 Boston Scientific Scimed, Inc. Implantable prosthesis having reinforced attachment sites
US20050288775A1 (en) * 2004-06-24 2005-12-29 Scimed Life Systems, Inc. Metallic fibers reinforced textile prosthesis
US7955373B2 (en) * 2004-06-28 2011-06-07 Boston Scientific Scimed, Inc. Two-stage stent-graft and method of delivering same
CA2570431C (en) * 2004-07-02 2012-11-27 Cook Incorporated Balloon / self-expanding stent graft
CA2591543A1 (en) * 2004-07-19 2006-02-09 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
US7344560B2 (en) 2004-10-08 2008-03-18 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US20080140187A1 (en) * 2004-10-15 2008-06-12 Krause Arthur A Anti-clotting, anti-microbial, anti-inflammatory medical stent
EP1804888B1 (en) 2004-10-15 2013-12-25 Bfkw, Llc Bariatric device
US7753907B2 (en) 2004-10-29 2010-07-13 Boston Scientific Scimed, Inc. Medical device systems and methods
US20060122694A1 (en) * 2004-12-03 2006-06-08 Stinson Jonathan S Medical devices and methods of making the same
US7722529B2 (en) * 2004-12-28 2010-05-25 Palo Alto Investors Expandable vessel harness for treating vessel aneurysms
US7318838B2 (en) * 2004-12-31 2008-01-15 Boston Scientific Scimed, Inc. Smart textile vascular graft
US7727273B2 (en) * 2005-01-13 2010-06-01 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
WO2006110197A2 (en) * 2005-03-03 2006-10-19 Icon Medical Corp. Polymer biodegradable medical device
US20060264914A1 (en) * 2005-03-03 2006-11-23 Icon Medical Corp. Metal alloys for medical devices
US8323333B2 (en) * 2005-03-03 2012-12-04 Icon Medical Corp. Fragile structure protective coating
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
US20060201601A1 (en) * 2005-03-03 2006-09-14 Icon Interventional Systems, Inc. Flexible markers
US7540995B2 (en) 2005-03-03 2009-06-02 Icon Medical Corp. Process for forming an improved metal alloy stent
AU2006221046B2 (en) * 2005-03-03 2012-02-02 Icon Medical Corp. Improved metal alloys for medical device
US8435280B2 (en) * 2005-03-31 2013-05-07 Boston Scientific Scimed, Inc. Flexible stent with variable width elements
US7641983B2 (en) * 2005-04-04 2010-01-05 Boston Scientific Scimed, Inc. Medical devices including composites
US8071155B2 (en) * 2005-05-05 2011-12-06 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US20060259126A1 (en) * 2005-05-05 2006-11-16 Jason Lenz Medical devices and methods of making the same
US20070010741A1 (en) * 2005-05-19 2007-01-11 Biophan Technologies, Inc. Electromagnetic resonant circuit sleeve for implantable medical device
CA2843097C (en) 2005-05-24 2015-10-27 Inspire M.D Ltd. Stent apparatuses for treatment via body lumens and methods of use
US8961586B2 (en) * 2005-05-24 2015-02-24 Inspiremd Ltd. Bifurcated stent assemblies
US8043323B2 (en) 2006-10-18 2011-10-25 Inspiremd Ltd. In vivo filter assembly
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US20060276875A1 (en) 2005-05-27 2006-12-07 Stinson Jonathan S Medical devices
US20090062909A1 (en) 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
AU2006270221B2 (en) 2005-07-15 2012-01-19 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
US7778684B2 (en) * 2005-08-08 2010-08-17 Boston Scientific Scimed, Inc. MRI resonator system with stent implant
DE202005012982U1 (en) * 2005-08-17 2005-10-27 Odu-Steckverbindungssysteme Gmbh & Co. Kg In line electrical connector has a plug with spring arm formed lugs that latch into holes in socket body to secure
US7540997B2 (en) 2005-08-23 2009-06-02 Boston Scientific Scimed, Inc. Medical devices having alloy compositions
EP1797843A1 (en) * 2005-12-14 2007-06-20 Thomas Ischinger Lesion specific stents, also for ostial lesions, and methods of application
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US8900287B2 (en) * 2006-01-13 2014-12-02 Aga Medical Corporation Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm
US8778008B2 (en) * 2006-01-13 2014-07-15 Aga Medical Corporation Intravascular deliverable stent for reinforcement of vascular abnormalities
US20080004689A1 (en) * 2006-01-19 2008-01-03 Linda Jahnke Systems and Methods for Making Medical Devices
US8089029B2 (en) 2006-02-01 2012-01-03 Boston Scientific Scimed, Inc. Bioabsorbable metal medical device and method of manufacture
US20070191930A1 (en) * 2006-02-15 2007-08-16 Paul Lucas Endovascular graft adapter
US8518098B2 (en) 2006-02-21 2013-08-27 Cook Medical Technologies Llc Split sheath deployment system
US8152833B2 (en) 2006-02-22 2012-04-10 Tyco Healthcare Group Lp Embolic protection systems having radiopaque filter mesh
DE602007001532D1 (en) * 2006-03-20 2009-08-20 Medical Device Works Nv Sa DEVICE FOR DELIVERING MEDICAL TREATMENT
US20070239256A1 (en) * 2006-03-22 2007-10-11 Jan Weber Medical devices having electrical circuits with multilayer regions
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US20080058785A1 (en) 2006-04-12 2008-03-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Autofluorescent imaging and target ablation
US20120035437A1 (en) 2006-04-12 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Navigation of a lumen traveling device toward a target
US8048150B2 (en) 2006-04-12 2011-11-01 Boston Scientific Scimed, Inc. Endoprosthesis having a fiber meshwork disposed thereon
ES2540059T3 (en) 2006-04-26 2015-07-08 Micell Technologies, Inc. Coatings containing multiple drugs
US8003156B2 (en) 2006-05-04 2011-08-23 Advanced Cardiovascular Systems, Inc. Rotatable support elements for stents
US7594928B2 (en) 2006-05-17 2009-09-29 Boston Scientific Scimed, Inc. Bioabsorbable stents with reinforced filaments
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
US8771343B2 (en) 2006-06-29 2014-07-08 Boston Scientific Scimed, Inc. Medical devices with selective titanium oxide coatings
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
US8047980B2 (en) 2006-07-10 2011-11-01 Mcneil-Ppc, Inc. Method of treating urinary incontinence
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
AU2007272601B2 (en) 2006-07-10 2014-01-16 First Quality Hygienic, Inc. Resilient device
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
WO2008008291A2 (en) * 2006-07-13 2008-01-17 Icon Medical Corp. Stent
EP2054537A2 (en) 2006-08-02 2009-05-06 Boston Scientific Scimed, Inc. Endoprosthesis with three-dimensional disintegration control
WO2008033711A2 (en) * 2006-09-14 2008-03-20 Boston Scientific Limited Medical devices with drug-eluting coating
CA2663220A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Medical devices and methods of making the same
WO2008034048A2 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprosthesis with biostable inorganic layers
US9402936B2 (en) * 2006-09-15 2016-08-02 Boston Scientific Scimed, Inc. Medical devices having alloy compositions
WO2008034031A2 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprostheses and methods of making the same
EP2081614A2 (en) * 2006-09-15 2009-07-29 Boston Scientific Scimed, Inc. Magnetized bioerodible endoprosthesis
JP2010503494A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Biodegradable endoprosthesis and method for producing the same
JP2010503490A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Endoprosthesis with adjustable surface features
EP2066271A1 (en) * 2006-09-18 2009-06-10 Boston Scientific Limited Medical device with porous surface
EP2068962B1 (en) 2006-09-18 2013-01-30 Boston Scientific Limited Endoprostheses
CA2663573C (en) * 2006-09-21 2015-04-07 Cleveny Technologies A specially configured and surface modified medical device with certain design features that utilize the intrinsic properties of tungsten, zirconium, tantalum and/or niobium
US7780798B2 (en) 2006-10-13 2010-08-24 Boston Scientific Scimed, Inc. Medical devices including hardened alloys
WO2008047368A2 (en) * 2006-10-18 2008-04-24 Inspiremd Ltd. Filter assemblies
US20100324664A1 (en) * 2006-10-18 2010-12-23 Asher Holzer Bifurcated Stent Assemblies
US20080140176A1 (en) * 2006-10-18 2008-06-12 Krause Arthur A Medical stent and devices for localized treatment of disease
CN102836023B (en) * 2006-10-18 2015-12-02 印斯拜尔Md有限公司 The support casing of braiding
US7614258B2 (en) 2006-10-19 2009-11-10 C.R. Bard, Inc. Prosthetic repair fabric
CN103767810B (en) 2006-10-22 2016-06-15 Idev科技公司 From the manufacturing process of extendable bracket
KR101659197B1 (en) 2006-10-22 2016-09-22 이데브 테크놀로지스, 아이엔씨. Devices and methods for stent advancement
US9539593B2 (en) 2006-10-23 2017-01-10 Micell Technologies, Inc. Holder for electrically charging a substrate during coating
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
CN101578078B (en) 2006-11-22 2013-01-02 印斯拜尔Md有限公司 Optimized stent jacket
US8768486B2 (en) * 2006-12-11 2014-07-01 Medtronic, Inc. Medical leads with frequency independent magnetic resonance imaging protection
WO2008082698A2 (en) * 2006-12-28 2008-07-10 Boston Scientific Limited Medical devices and methods of making the same
ES2506144T3 (en) 2006-12-28 2014-10-13 Boston Scientific Limited Bioerodible endoprosthesis and their manufacturing procedure
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
US9737642B2 (en) 2007-01-08 2017-08-22 Micell Technologies, Inc. Stents having biodegradable layers
US8523931B2 (en) 2007-01-12 2013-09-03 Endologix, Inc. Dual concentric guidewire and methods of bifurcated graft deployment
US7972375B2 (en) * 2007-02-05 2011-07-05 Boston Scientific Scimed, Inc. Endoprostheses including metal matrix composite structures
US8529431B2 (en) 2007-02-14 2013-09-10 Bfkw, Llc Bariatric device and method
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8177834B2 (en) 2007-03-12 2012-05-15 Cook Medical Technologies Llc Woven fabric with shape memory element strands
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
AU2008256684B2 (en) 2007-05-25 2012-06-14 Micell Technologies, Inc. Polymer films for medical device coating
US8211162B2 (en) * 2007-05-25 2012-07-03 Boston Scientific Scimed, Inc. Connector node for durable stent
US7921678B2 (en) * 2007-06-20 2011-04-12 Atex Technologies, Inc. Compressible resilient fabric, devices, and methods
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
JP5734650B2 (en) 2007-06-25 2015-06-17 マイクロベンション インコーポレイテッド Self-expanding prosthesis
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7604662B2 (en) * 2007-07-13 2009-10-20 Boston Scientific Scimed, Inc. Endoprostheses containing boride intermetallic phases
US9284409B2 (en) 2007-07-19 2016-03-15 Boston Scientific Scimed, Inc. Endoprosthesis having a non-fouling surface
US20090030500A1 (en) * 2007-07-27 2009-01-29 Jan Weber Iron Ion Releasing Endoprostheses
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8221822B2 (en) 2007-07-31 2012-07-17 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
WO2009020520A1 (en) 2007-08-03 2009-02-12 Boston Scientific Scimed, Inc. Coating for medical device having increased surface area
US7883736B2 (en) * 2007-09-06 2011-02-08 Boston Scientific Scimed, Inc. Endoprostheses having porous claddings prepared using metal hydrides
US8052745B2 (en) 2007-09-13 2011-11-08 Boston Scientific Scimed, Inc. Endoprosthesis
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
AU2008308474B2 (en) 2007-10-04 2014-07-24 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8834552B2 (en) * 2007-12-27 2014-09-16 Cook Medical Technologies Llc Stent graft having floating yarns
US8623071B2 (en) * 2008-01-07 2014-01-07 DePuy Synthes Products, LLC Radiopaque super-elastic intravascular stent
US20090192588A1 (en) * 2008-01-29 2009-07-30 Taeoong Medical Co., Ltd Biodegradable double stent
US8221494B2 (en) 2008-02-22 2012-07-17 Endologix, Inc. Apparatus and method of placement of a graft or graft system
US8196279B2 (en) 2008-02-27 2012-06-12 C. R. Bard, Inc. Stent-graft covering process
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
CA2721832C (en) 2008-04-17 2018-08-07 Micell Technologies, Inc. Stents having bioabsorbable layers
US20090318948A1 (en) * 2008-04-22 2009-12-24 Coherex Medical, Inc. Device, system and method for aneurysm embolization
JP5581311B2 (en) 2008-04-22 2014-08-27 ボストン サイエンティフィック サイムド,インコーポレイテッド MEDICAL DEVICE HAVING INORGANIC MATERIAL COATING AND MANUFACTURING METHOD THEREOF
US8932346B2 (en) 2008-04-24 2015-01-13 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US7998192B2 (en) 2008-05-09 2011-08-16 Boston Scientific Scimed, Inc. Endoprostheses
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US8236046B2 (en) 2008-06-10 2012-08-07 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US20090312645A1 (en) * 2008-06-16 2009-12-17 Boston Scientific Scimed, Inc. Methods and Devices for Accessing Anatomic Structures
WO2009155328A2 (en) 2008-06-18 2009-12-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
JP5134729B2 (en) 2008-07-01 2013-01-30 エンドロジックス、インク Catheter system
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
JP2011528275A (en) 2008-07-17 2011-11-17 ミセル テクノロジーズ,インク. Drug delivery medical device
US7985252B2 (en) 2008-07-30 2011-07-26 Boston Scientific Scimed, Inc. Bioerodible endoprosthesis
US8353943B2 (en) * 2008-08-29 2013-01-15 Cook Medical Technologies Llc Variable weave graft with metal strand reinforcement for in situ fenestration
WO2010033370A2 (en) * 2008-09-17 2010-03-25 National Ict Australia Limited (Nicta) Knitted catheter
US8382824B2 (en) 2008-10-03 2013-02-26 Boston Scientific Scimed, Inc. Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US9427304B2 (en) * 2008-10-27 2016-08-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer device with gap for treating a target site and associated method
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US9204953B2 (en) * 2008-12-15 2015-12-08 Allergan, Inc. Biocompatible surgical scaffold with varying stretch
US20120150204A1 (en) * 2008-12-15 2012-06-14 Allergan, Inc. Implantable silk prosthetic device and uses thereof
KR101707249B1 (en) * 2008-12-15 2017-02-15 알러간, 인코포레이티드 A prosthetic device and method of manufacturing the same
US9308070B2 (en) * 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
US9204954B2 (en) * 2008-12-15 2015-12-08 Allergan, Inc. Knitted scaffold with diagonal yarn
US9326840B2 (en) * 2008-12-15 2016-05-03 Allergan, Inc. Prosthetic device and method of manufacturing the same
US8834913B2 (en) 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
US20100217370A1 (en) * 2009-02-20 2010-08-26 Boston Scientific Scimed, Inc. Bioerodible Endoprosthesis
WO2010101901A2 (en) 2009-03-02 2010-09-10 Boston Scientific Scimed, Inc. Self-buffering medical implants
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
WO2010111666A1 (en) * 2009-03-26 2010-09-30 Taheri Laduca Llc Vascular implants and methods
CN102481195B (en) 2009-04-01 2015-03-25 米歇尔技术公司 Drug delivery medical device
US8435281B2 (en) 2009-04-10 2013-05-07 Boston Scientific Scimed, Inc. Bioerodible, implantable medical devices incorporating supersaturated magnesium alloys
EP3366326A1 (en) 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
US8202301B2 (en) * 2009-04-24 2012-06-19 Warsaw Orthopedic, Inc. Dynamic spinal rod and implantation method
EP2429452B1 (en) 2009-04-28 2020-01-15 Endologix, Inc. Endoluminal prosthesis system
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US20100292776A1 (en) * 2009-05-14 2010-11-18 Boston Scientific Scimed, Inc. Bioerodible Endoprosthesis
JP5820370B2 (en) * 2009-05-20 2015-11-24 アーセナル メディカル, インコーポレイテッド Medical implant
US9265633B2 (en) 2009-05-20 2016-02-23 480 Biomedical, Inc. Drug-eluting medical implants
US8556957B2 (en) * 2009-06-18 2013-10-15 Medtronic Vascular, Inc. Biodegradable medical device with hydroxyapatite filaments and biodegradable polymer fibers
US8491646B2 (en) 2009-07-15 2013-07-23 Endologix, Inc. Stent graft
WO2011017123A2 (en) 2009-07-27 2011-02-10 Endologix, Inc. Stent graft
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US10092427B2 (en) 2009-11-04 2018-10-09 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US20110160839A1 (en) 2009-12-29 2011-06-30 Boston Scientific Scimed, Inc. Endoprosthesis
WO2011097103A1 (en) 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US8398916B2 (en) 2010-03-04 2013-03-19 Icon Medical Corp. Method for forming a tubular medical device
CN103037929B (en) 2010-03-06 2015-08-26 新融合血管系统有限公司 Reclaim catheter kit
US8668732B2 (en) 2010-03-23 2014-03-11 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
US8709072B2 (en) 2010-05-13 2014-04-29 Boston Scientific Scimed, Inc. Endoprosthesis
US9314551B2 (en) 2010-05-14 2016-04-19 Boston Scientific Scimed, Inc. Block copolymer-coated endoprosthesis
US9023095B2 (en) 2010-05-27 2015-05-05 Idev Technologies, Inc. Stent delivery system with pusher assembly
CA2805631C (en) 2010-07-16 2018-07-31 Micell Technologies, Inc. Drug delivery medical device
WO2012044917A1 (en) * 2010-10-01 2012-04-05 Bfkw, Llc Intraluminal device and method
US20120109279A1 (en) 2010-11-02 2012-05-03 Endologix, Inc. Apparatus and method of placement of a graft or graft system
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
US8833402B2 (en) * 2010-12-30 2014-09-16 Cook Medical Technologies Llc Woven fabric having composite yarns for endoluminal devices
EP2658484A1 (en) 2010-12-30 2013-11-06 Boston Scientific Scimed, Inc. Multi stage opening stent designs
CN105232195B (en) 2011-03-01 2018-06-08 恩朵罗杰克斯股份有限公司 Delivery catheter system
JP2014511247A (en) 2011-03-03 2014-05-15 ボストン サイエンティフィック サイムド,インコーポレイテッド Low strain high strength stent
WO2012119037A1 (en) 2011-03-03 2012-09-07 Boston Scientific Scimed, Inc. Stent with reduced profile
CA2835427A1 (en) 2011-05-11 2012-11-15 Microvention, Inc. Device for occluding a lumen
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US9345532B2 (en) 2011-05-13 2016-05-24 Broncus Medical Inc. Methods and devices for ablation of tissue
JP6162690B2 (en) 2011-05-20 2017-07-12 ビーエフケイダブリュ・リミテッド・ライアビリティ・カンパニーBfkw, Llc Intraluminal device with increased anti-migration and intraluminal methods
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
US10117972B2 (en) 2011-07-15 2018-11-06 Micell Technologies, Inc. Drug delivery medical device
CN102296415A (en) * 2011-07-21 2011-12-28 天津波柔婷针纺织品有限公司 Method for weaving artificial blood vessel
US8621975B2 (en) 2011-09-20 2014-01-07 Aga Medical Corporation Device and method for treating vascular abnormalities
US9039752B2 (en) 2011-09-20 2015-05-26 Aga Medical Corporation Device and method for delivering a vascular device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
WO2013078235A1 (en) 2011-11-23 2013-05-30 Broncus Medical Inc Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
CA3082787C (en) 2011-12-06 2021-03-09 Aortic Innovations Llc Device for endovascular aortic repair and method of using the same
DE102011056922A1 (en) * 2011-12-22 2013-06-27 Alfred Buck Method for manufacturing tubular knitting for use as implant or stent for insertion into arterial blood vessels, involves generating circular knitted fabric with biocompatible marking material and reversing generated circular knitted fabric
WO2013128012A1 (en) 2012-03-01 2013-09-06 Medical Device Works Nv System for monitoring and controlling organ blood perfusion
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
NZ701992A (en) 2012-05-14 2016-03-31 Bard Inc C R Uniformly expandable stent
US9108029B2 (en) 2012-05-21 2015-08-18 Nfusion Vascular Systems, Llc Recovery catheter assembly and method
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9301831B2 (en) 2012-10-30 2016-04-05 Covidien Lp Methods for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) * 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
CN102973341B (en) * 2012-11-08 2015-06-17 先健科技(深圳)有限公司 Braided self-expanding type tube cavity support and manufacturing method thereof
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
AU2014248508B2 (en) 2013-03-12 2018-11-08 Micell Technologies, Inc. Bioabsorbable biomedical implants
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
JP2016519965A (en) 2013-05-15 2016-07-11 マイセル・テクノロジーズ,インコーポレイテッド Bioabsorbable biomedical implant
US9968716B2 (en) 2013-10-15 2018-05-15 Ono Pharmaceutical Co., Ltd. Drug-eluting stent graft
US9918858B2 (en) 2014-05-30 2018-03-20 Boston Scientific Scimed, Inc. Endoluminal stents and methods of delivery
US9901722B2 (en) 2014-06-01 2018-02-27 White Swell Medical Ltd System and method for treatment of pulmonary edema
BR112016030273A2 (en) 2014-06-24 2017-08-22 Icon Medical Corp MEDICAL DEVICE AND METHOD FOR FORMING SAID DEVICE
US10184194B2 (en) 2014-07-28 2019-01-22 The Boeing Company Multi-material integrated knit thermal protection for industrial and vehicle applications
US11020213B2 (en) 2014-12-29 2021-06-01 Bfkw, Llc Fixation of intraluminal device
BR112017013168A2 (en) 2014-12-29 2018-01-02 Bfkw, Llc intraluminal device fixation
US11013629B2 (en) 2014-12-29 2021-05-25 Bfkw, Llc Fixation of intraluminal device
DE102015104884A1 (en) * 2015-03-30 2016-10-06 Serag-Wiessner Gmbh & Co. Kg Textile implant
EP3970765A1 (en) 2015-05-11 2022-03-23 White Swell Medical Ltd Systems for reducing pressure at an outflow of a duct
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
US11766506B2 (en) 2016-03-04 2023-09-26 Mirus Llc Stent device for spinal fusion
CN105769383B (en) * 2016-03-18 2019-12-10 杭州唯强医疗科技有限公司 Aorta bare stent and aorta interlayer stent
WO2017176553A1 (en) 2016-04-05 2017-10-12 Boston Scientific Scimed, Inc. Stent delivery device
US10426592B2 (en) 2016-04-11 2019-10-01 Boston Scientific Scimed, Inc. Implantable medical device with reduced migration capabilities
WO2018005969A1 (en) * 2016-06-30 2018-01-04 Washington University Device and method of inhibiting endoleaks
RU2691324C1 (en) * 2016-07-11 2019-06-11 Вячеслав Васильевич Аверьянов Prosthesis for plastics of large and medium vessels
AU2017353938B2 (en) 2016-11-01 2022-10-20 White Swell Medical Ltd Systems and methods for treatment of fluid overload
WO2018156948A1 (en) 2017-02-23 2018-08-30 Boston Scientific Scimed, Inc. Medical drain device
EP3589217B1 (en) 2017-03-02 2023-06-28 White Swell Medical Ltd Systems and methods for reducing pressure at outflow of a duct
US11406393B2 (en) 2017-03-19 2022-08-09 White Swell Medical Ltd Methods and devices for reducing pressure
JP7013591B2 (en) 2017-12-18 2022-01-31 ボストン サイエンティフィック サイムド,インコーポレイテッド Closure device with expandable members
WO2019144072A1 (en) 2018-01-19 2019-07-25 Boston Scientific Scimed, Inc. Occlusive medical device with delivery system
KR102471885B1 (en) 2018-04-09 2022-11-28 보스톤 싸이엔티픽 싸이메드 인코포레이티드 stent
WO2019213274A1 (en) 2018-05-02 2019-11-07 Boston Scientific Scimed, Inc. Occlusive sealing sensor system
US11241239B2 (en) 2018-05-15 2022-02-08 Boston Scientific Scimed, Inc. Occlusive medical device with charged polymer coating
EP3569200A1 (en) 2018-05-18 2019-11-20 Eucatech AG Tubular knitted stents
WO2019237004A1 (en) 2018-06-08 2019-12-12 Boston Scientific Scimed, Inc. Medical device with occlusive member
EP3801301A1 (en) 2018-06-08 2021-04-14 Boston Scientific Scimed Inc. Occlusive device with actuatable fixation members
WO2020010201A1 (en) 2018-07-06 2020-01-09 Boston Scientific Scimed, Inc. Occlusive medical device
US11925570B2 (en) 2018-12-19 2024-03-12 Boston Scientific Scimed, Inc. Stent including anti-migration capabilities
JP7348292B2 (en) 2019-01-07 2023-09-20 ボストン サイエンティフィック サイムド,インコーポレイテッド Stent with anti-migration mechanism
US11660426B2 (en) 2019-02-26 2023-05-30 White Swell Medical Ltd Devices and methods for treating edema
US11724095B2 (en) 2019-02-26 2023-08-15 White Swell Medical Ltd Devices and methods for treating edema
US11793996B2 (en) 2019-02-26 2023-10-24 White Swell Medical Ltd Devices and methods for treating edema
US11931560B2 (en) 2019-02-26 2024-03-19 White Swell Medical Ltd Devices and methods for treating edema
US11717652B2 (en) 2019-02-26 2023-08-08 White Swell Medical Ltd Devices and methods for treating edema
EP3998962A1 (en) 2019-07-17 2022-05-25 Boston Scientific Scimed, Inc. Left atrial appendage implant with continuous covering
CN114340516A (en) 2019-08-30 2022-04-12 波士顿科学医学有限公司 Left atrial appendage implant with sealing disk
WO2021158564A1 (en) * 2020-02-03 2021-08-12 Boston Scientific Scimed, Inc. Stent, mandrel, and method for forming a stent with anti-migration features
TWI770801B (en) * 2020-03-09 2022-07-11 陳階曉 Medical device for distracting target site
WO2021195085A1 (en) 2020-03-24 2021-09-30 Boston Scientific Scimed, Inc. Medical system for treating a left atrial appendage
WO2022119891A1 (en) 2020-12-02 2022-06-09 Boston Scientific Scimed, Inc. Stent with improved deployment characteristics

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173811A (en) * 1967-02-28 1969-12-10 Meadox Medicals Inc Surgical Implants
EP0364787A1 (en) * 1988-10-04 1990-04-25 EXPANDABLE GRAFTS PARTNERSHIP a Texas General Partnership Expandable intraluminal graft
US4922905A (en) * 1985-11-30 1990-05-08 Strecker Ernst P Dilatation catheter
US4990158A (en) * 1989-05-10 1991-02-05 United States Surgical Corporation Synthetic semiabsorbable tubular prosthesis

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1205743A (en) * 1966-07-15 1970-09-16 Nat Res Dev Surgical dilator
US3657744A (en) * 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4130904A (en) * 1977-06-06 1978-12-26 Thermo Electron Corporation Prosthetic blood conduit
US4164045A (en) * 1977-08-03 1979-08-14 Carbomedics, Inc. Artificial vascular and patch grafts
US4300244A (en) * 1979-09-19 1981-11-17 Carbomedics, Inc. Cardiovascular grafts
US4327736A (en) * 1979-11-20 1982-05-04 Kanji Inoue Balloon catheter
US4816029A (en) * 1981-05-07 1989-03-28 Medtronic, Inc. Stent for aortic heart valve
US4619247A (en) * 1983-03-31 1986-10-28 Sumitomo Electric Industries, Ltd. Catheter
US4626255A (en) * 1983-09-23 1986-12-02 Christian Weinhold Heart valve bioprothesis
JPS635697Y2 (en) * 1985-04-04 1988-02-17
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
JPS6346171A (en) * 1986-06-06 1988-02-27 旭光学工業株式会社 Support of medical device stayed in living body
US4840635A (en) * 1986-08-08 1989-06-20 Knit-Rite, Inc. Full-fashion stump shrinker for the residual limb of a human amputee
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4892539A (en) * 1988-02-08 1990-01-09 D-R Medical Systems, Inc. Vascular graft
GB2225034B (en) * 1988-11-17 1992-07-22 Chatsworth Knitting Ltd Knitted stretch lace
US5147400A (en) * 1989-05-10 1992-09-15 United States Surgical Corporation Connective tissue prosthesis
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5015253A (en) * 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
DK0441516T3 (en) * 1990-02-08 1995-06-12 Howmedica Inflatable catheter
EP0461791B1 (en) * 1990-06-11 1997-01-02 Hector D. Barone Aortic graft and apparatus for repairing an abdominal aortic aneurysm
US5236447A (en) 1990-06-29 1993-08-17 Nissho Corporation Artificial tubular organ
DE9014230U1 (en) * 1990-10-13 1991-11-21 Angiomed Ag, 7500 Karlsruhe, De
JPH0717314Y2 (en) * 1990-10-18 1995-04-26 ソン ホーヨン Self-expanding intravascular stent
DE4137857A1 (en) * 1990-11-26 1992-05-27 Ernst Peter Prof Dr M Strecker DEVICE WITH A PROSTHESIS IMPLANTABLE IN THE BODY OF A PATIENT
US5366504A (en) * 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5876445A (en) * 1991-10-09 1999-03-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5370683A (en) * 1992-03-25 1994-12-06 Cook Incorporated Vascular stent
JPH07505316A (en) * 1992-03-31 1995-06-15 ボストン サイエンティフィック コーポレーション medical wire
US5405378A (en) * 1992-05-20 1995-04-11 Strecker; Ernst P. Device with a prosthesis implantable in the body of a patient
EP1181904B1 (en) * 1994-10-17 2009-06-24 Kabushikikaisha Igaki Iryo Sekkei Stent for liberating drug

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173811A (en) * 1967-02-28 1969-12-10 Meadox Medicals Inc Surgical Implants
US4922905A (en) * 1985-11-30 1990-05-08 Strecker Ernst P Dilatation catheter
EP0364787A1 (en) * 1988-10-04 1990-04-25 EXPANDABLE GRAFTS PARTNERSHIP a Texas General Partnership Expandable intraluminal graft
US4990158A (en) * 1989-05-10 1991-02-05 United States Surgical Corporation Synthetic semiabsorbable tubular prosthesis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Applicant's Knowledge (03 May 1993), see the Supplemental Information Disclosure. *

Cited By (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5653747A (en) * 1992-12-21 1997-08-05 Corvita Corporation Luminal graft endoprostheses and manufacture thereof
US5871538A (en) * 1992-12-21 1999-02-16 Corvita Corporation Luminal graft endoprotheses and manufacture thereof
US5948018A (en) * 1993-10-21 1999-09-07 Corvita Corporation Expandable supportive endoluminal grafts
US5632772A (en) * 1993-10-21 1997-05-27 Corvita Corporation Expandable supportive branched endoluminal grafts
US5639278A (en) * 1993-10-21 1997-06-17 Corvita Corporation Expandable supportive bifurcated endoluminal grafts
US6165212A (en) * 1993-10-21 2000-12-26 Corvita Corporation Expandable supportive endoluminal grafts
US6309413B1 (en) 1993-10-21 2001-10-30 Corvita Corporation Expandable supportive endoluminal grafts
US5855598A (en) * 1993-10-21 1999-01-05 Corvita Corporation Expandable supportive branched endoluminal grafts
US5723004A (en) * 1993-10-21 1998-03-03 Corvita Corporation Expandable supportive endoluminal grafts
US5733325A (en) * 1993-11-04 1998-03-31 C. R. Bard, Inc. Non-migrating vascular prosthesis and minimally invasive placement system
EP1433439A3 (en) * 1994-04-28 2005-07-20 Boston Scientific Corporation Endoprothesis
EP1433439A2 (en) 1994-04-28 2004-06-30 Boston Scientific Corporation Endoprothesis
US6602279B1 (en) 1994-04-28 2003-08-05 Boston Scientific Corporation Placement of endoprostheses and stents
EP0757571A4 (en) * 1994-04-28 1999-04-07 Boston Scient Corp Placement of endoprostheses and stents
EP0757571A1 (en) * 1994-04-28 1997-02-12 Boston Scientific Corporation Placement of endoprostheses and stents
US6620190B1 (en) 1994-05-06 2003-09-16 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Radially expandable polytetrafluoroethylene
US6098630A (en) * 1994-06-13 2000-08-08 Endomed Inc. Multiple diameter expandable graft for blood vessel and method for deploying the same
US7465483B2 (en) 1994-06-27 2008-12-16 C.R.Bard Inc. Radially expandable polytetrafluoroethylene
EP0689806A3 (en) * 1994-06-28 1997-06-25 Meadox Medicals Inc Implantable tubular prosthesis having cuffs
EP0689806A2 (en) * 1994-06-28 1996-01-03 Meadox Medicals, Inc. Implantable tubular prosthesis having cuffs
EP1181904A3 (en) * 1994-10-17 2003-07-16 Kabushikikaisha Igaki Iryo Sekkei Stent for liberating drug
EP1181904A2 (en) * 1994-10-17 2002-02-27 Kabushikikaisha Igaki Iryo Sekkei Stent for liberating drug
EP1477132A2 (en) * 1994-10-17 2004-11-17 Kabushikikaisha Igaki Iryo Sekkei Drug-releasing stent
EP0761251A1 (en) * 1994-10-17 1997-03-12 Kabushikikaisha Igaki Iryo Sekkei Drug-releasing stent
EP1477132A3 (en) * 1994-10-17 2009-09-09 Kabushikikaisha Igaki Iryo Sekkei Drug-releasing stent
EP0761251A4 (en) * 1994-10-17 1999-03-31 Igaki Iryo Sekkei Kk Drug-releasing stent
EP2103277A3 (en) * 1994-10-18 2010-01-20 TERAMed Corporation Apparatus for deploying stents
US6120536A (en) * 1995-04-19 2000-09-19 Schneider (Usa) Inc. Medical devices with long term non-thrombogenic coatings
EP1281374A3 (en) * 1995-10-11 2003-07-09 Schneider (Usa) Inc. Braided prosthesis
WO1997013475A1 (en) * 1995-10-11 1997-04-17 Schneider (Usa) Inc. Braided composite prosthesis
US6554858B2 (en) 1996-04-25 2003-04-29 Corvita Europe Intraluminal endoprosthesis for ramifying the ducts of a human or animal body and method of manufacture thereof
EP0804909A2 (en) * 1996-04-30 1997-11-05 Schneider (Usa) Inc. Three dimensional braided covered stent
AU729170B2 (en) * 1996-04-30 2001-01-25 Schneider (Usa) Inc. Three-dimensional braided covered stent
EP0804909A3 (en) * 1996-04-30 1998-10-14 Schneider (Usa) Inc. Three dimensional braided covered stent
WO1998019636A2 (en) * 1996-11-07 1998-05-14 Vascular Science Inc. Medical grafting methods and apparatus
WO1998019636A3 (en) * 1996-11-07 1998-10-08 Vascular Science Inc Medical grafting methods and apparatus
WO1998019629A2 (en) * 1996-11-07 1998-05-14 Vascular Science Inc. Medical grafting connectors and fasteners
WO1998019629A3 (en) * 1996-11-07 1998-09-11 Vascular Science Inc Medical grafting connectors and fasteners
US5980972A (en) * 1996-12-20 1999-11-09 Schneider (Usa) Inc Method of applying drug-release coatings
US8790238B2 (en) 1997-02-13 2014-07-29 Boston Scientific Scimed, Inc. Systems, devices, and methods for minimally invasive pelvic surgery
US9314323B2 (en) 1997-02-13 2016-04-19 Boston Scientific Scimed, Inc. Systems, devices and methods for minimally invasive pelvic surgery
US7691050B2 (en) 1997-02-13 2010-04-06 Boston Scientific Scimed, Inc. Devices for minimally invasive pelvic surgery
US7413540B2 (en) 1997-02-13 2008-08-19 Boston Scientific Scimed, Inc. Devices for minimally invasive pelvic surgery
EP0916362A4 (en) * 1997-03-31 2005-05-25 Igaki Iryo Sekkei Kk Stent for vessels
EP0916362A1 (en) * 1997-03-31 1999-05-19 Kabushikikaisha Igaki Iryo Sekkei Stent for vessels
US6036702A (en) * 1997-04-23 2000-03-14 Vascular Science Inc. Medical grafting connectors and fasteners
US7211095B2 (en) 1997-04-23 2007-05-01 St. Jude Medical Atg, Inc. Medical grafting connectors and fasteners
US6702829B2 (en) 1997-04-23 2004-03-09 St. Jude Medical Atg, Inc. Medical grafting connectors and fasteners
US7850705B2 (en) 1997-04-23 2010-12-14 St. Jude Medical Atg, Inc. Medical grafting connectors and fasteners
US6994713B2 (en) 1998-01-30 2006-02-07 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
US6660015B1 (en) 1998-01-30 2003-12-09 St. Jude Medical Atg, Inc. Medical graft connector or plug structures, and methods of making and installing same
US6620176B1 (en) 1998-11-06 2003-09-16 St. Jude Medical Atg, Inc. Medical graft connector and methods of making and installing same
US6113612A (en) * 1998-11-06 2000-09-05 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US6673084B1 (en) 1998-11-06 2004-01-06 St. Jude Medical Atg, Inc. Medical graft connector
US6533812B2 (en) 1998-11-06 2003-03-18 St. Jude Medical Atg, Inc. Medical anastomosis apparatus
US8632555B2 (en) 1998-11-06 2014-01-21 St. Jude Medical, Cardiology Division, Inc. Medical graft connector and methods of making and installing same
US6508822B1 (en) 1998-11-06 2003-01-21 St. Jude Medical Atg, Inc. Medical graft assembly
US6440163B1 (en) 1998-11-06 2002-08-27 St. Jude Medical Atg, Inc. Medical anastomosis apparatus
US6599303B1 (en) 1998-11-06 2003-07-29 St. Jude Medical Atg, Inc. Medical graft connector and methods of making and installing same
US6309416B1 (en) 1998-11-06 2001-10-30 St. Jude Medical Cardiovascular Group, Inc. Medical anastomosis apparatus
US6152937A (en) * 1998-11-06 2000-11-28 St. Jude Medical Cardiovascular Group, Inc. Medical graft connector and methods of making and installing same
US6712836B1 (en) 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US7794775B2 (en) 1999-06-24 2010-09-14 Biocompatibles Limited Balloon expandable stent
US7306625B1 (en) 1999-06-24 2007-12-11 Abbott Laboratories Balloon expandable stent
US8052746B2 (en) 1999-06-24 2011-11-08 Biocompatibles Limited Balloon expandable stent
US6602263B1 (en) 1999-11-30 2003-08-05 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
US6866674B2 (en) 1999-11-30 2005-03-15 St. Jude Medical Atg, Inc. Medical grafting methods and apparatus
WO2001056499A1 (en) 2000-01-31 2001-08-09 Ethicon Gmbh Areal implant with x-ray-visible elements
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
WO2002022049A2 (en) 2000-09-12 2002-03-21 Georgios Archodoulakis Implantable prosthesis for intravascular applications
US8303609B2 (en) 2000-09-29 2012-11-06 Cordis Corporation Coated medical devices
EP1343435A4 (en) * 2000-10-31 2006-05-24 Prodesco Graft having region for biological seal formation
EP1343435A2 (en) * 2000-10-31 2003-09-17 Prodesco , Inc. Graft having region for biological seal formation
US8182527B2 (en) 2001-05-07 2012-05-22 Cordis Corporation Heparin barrier coating for controlled drug release
US7717937B2 (en) 2001-06-01 2010-05-18 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US9078630B2 (en) 2001-06-01 2015-07-14 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
GB2378137A (en) * 2001-07-31 2003-02-05 John Reece Jenkins A stent comprising a framework of shape memory metal
EP1308138A3 (en) * 2001-10-30 2003-07-30 Olympus Optical Co., Ltd. Stent
US6878159B2 (en) 2001-10-30 2005-04-12 Olympus Corporation Stent
EP1455687B1 (en) * 2001-12-19 2014-09-10 Cook Medical Technologies LLC Stent graft with improved graft adhesion
US7976564B2 (en) 2002-05-06 2011-07-12 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
US7691128B2 (en) 2002-05-06 2010-04-06 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US8574264B2 (en) 2003-04-11 2013-11-05 St. Jude Medical, Cardiology Division, Inc. Method for retrieving a closure device
US8114102B2 (en) 2003-06-16 2012-02-14 St. Jude Medical Atg, Inc. Temporary hemostatic plug apparatus and method of use
DE102004008459A1 (en) * 2004-02-17 2005-09-01 Aesculap Ag & Co. Kg Implant, useful as stents, comprises a fabric and at least a radiopaque marker, which passes in a direction along the implant
EP1769774A1 (en) * 2005-10-03 2007-04-04 Noureddine Frid Radiopaque endoprostheses
US8353951B2 (en) 2005-10-03 2013-01-15 Cardiatis S.A. Radio-opaque endoprosthesis
WO2007039587A1 (en) * 2005-10-03 2007-04-12 Noureddine Frid Radio-opaque endoprosthesis
EP2512369A4 (en) * 2009-12-16 2015-11-25 Neograft Technologies Inc Graft devices and methods of use
US9603729B2 (en) 2009-12-16 2017-03-28 Neograft Technologies, Inc. Graft devices and related systems and methods
US10076427B2 (en) 2009-12-16 2018-09-18 Neograft Technologies, Inc. Graft devices and related systems and methods
WO2013160829A1 (en) * 2012-04-23 2013-10-31 St George Medical Inc Intravascular prosthesis for small vessels
FR2989567A1 (en) * 2012-04-23 2013-10-25 St George Medical Inc ENDOLUMINAL VASCULAR PROSTHESIS FOR SMALL VESSELS
EP3569192A1 (en) * 2015-01-16 2019-11-20 Boston Scientific Scimed, Inc. Implantable medical device with reduced migration capabilities
US10524939B2 (en) 2015-01-16 2020-01-07 Boston Scientific Scimed, Inc. Implantable medical device with reduced migration capabilities
US11147695B2 (en) 2015-01-16 2021-10-19 Boston Scientific Scimed, Inc. Implantable medical device with reduced migration capabilities
WO2021083505A1 (en) * 2019-10-30 2021-05-06 Angiomed Gmbh & Co. Medizintechnik Kg Tips stent graft and kit

Also Published As

Publication number Publication date
DE69332800D1 (en) 2003-04-30
CA2139564C (en) 2004-10-05
EP0651624B1 (en) 2003-03-26
US5366504A (en) 1994-11-22
JPH07509152A (en) 1995-10-12
EP0651624A1 (en) 1995-05-10
DE69332800T2 (en) 2003-09-18
EP0651624A4 (en) 1995-08-09
US5674276A (en) 1997-10-07
US6221099B1 (en) 2001-04-24
CA2139564A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
US5366504A (en) Tubular medical prosthesis
US6161399A (en) Process for manufacturing a wire reinforced monolayer fabric stent
US6398807B1 (en) Braided branching stent, method for treating a lumen therewith, and process for manufacture therefor
EP1049420B1 (en) Reinforced graft
US7520890B2 (en) Reinforced graft and method of deployment
JP5350867B2 (en) Remotely removable cover and support
US7004967B2 (en) Process for manufacturing a braided bifurcated stent
US7938853B2 (en) Braided endoluminal device having tapered filaments
US20050154446A1 (en) Reinforced graft
EP2769699B1 (en) Attachment of stent to graft fabric with an anchoring machine stitching
US20160143756A1 (en) Endovascular medical device
US20040186549A1 (en) Braided stent with looped ends and method for making same
US20230277345A1 (en) Methods of using a self-adjusting stent assembly and kits including same
JP2021526429A (en) Systems and methods for constructing restraint mechanisms on devices

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2139564

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1993917107

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993917107

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1993917107

Country of ref document: EP